CDCES Practice Test

Certified Diabetes Care and Education Specialist (CDCES)

CDCES overview

  • 200 practice questions
  • 32 flashcards
  • 5 study guide topics
  • 38 key terms

What you'll study

  • Diabetes pathophysiology, epidemiology, and prevention20%
  • Clinical management: pharmacotherapy and glycemic targets20%
  • Nutrition, physical activity, and weight management20%
  • Diabetes self-management education, behavior change, and psychosocial care20%
  • Monitoring, technology, complications, and special populations20%

The Certified Diabetes Care and Education Specialist (CDCES) credential is a professional certification administered by the Certification Board for Diabetes Care and Education (CBDCE). CBDCE describes the credential as recognizing health professionals with specialized expertise in diabetes prevention, prediabetes, and diabetes management, and notes that within their role, CDCES professionals educate, support, and advocate for people living with diabetes. Employers, healthcare providers, and people with diabetes look for the CDCES credential when working with a diabetes care and education specialist.

The credential is aimed at licensed health professionals - nurses, dietitians, pharmacists and others - whose practice centers on diabetes education and support. The exam samples that whole scope of practice: pathophysiology, epidemiology and prevention; pharmacotherapy and glycemic targets; nutrition, physical activity and weight management; self-management education, behavior change and psychosocial care; and monitoring, technology, complications and special populations.

Preparation is largely self-directed. CBDCE publishes eligibility requirements, an About the Exam page, exam preparation resources, and a list of CBDCE-Recognized Preparation Pathways, and candidates apply for and schedule testing through their CBDCE account. This page is independent study material and is not affiliated with, endorsed by, or sponsored by CBDCE; always confirm current eligibility rules, fees, scheduling and renewal details with CBDCE before you register.

Common mistakes

Answering diagnostic-criteria items by applying a single A1c cutoff (6.5%) to every population and every clinical situation, including pregnancy, recent transfusion, hemoglobinopathy, or advanced CKD.

Candidates memorize the 6.5% number but not the conditions that make A1c unreliable, and they forget that gestational diabetes is diagnosed with OGTT thresholds rather than A1c.

What to do instead

Build a one-page decision grid: fasting plasma glucose ≥126, 2-hour 75-g OGTT ≥200, random ≥200 with symptoms, A1c ≥6.5% - then write beside it the list of A1c-invalidating states (hemolysis, transfusion, iron deficiency, hemoglobin variants, pregnancy, dialysis) and use OGTT/FPG there.

Recommending 'lose some weight and exercise' for prediabetes instead of citing the specific Diabetes Prevention Program targets and effect size, or choosing pharmacotherapy as first-line for every patient with prediabetes.

The DPP numbers (about 7% weight loss, 150 min/week of moderate activity, roughly 58% reduction in progression) are frequently mixed up with other trials or half-remembered.

What to do instead

Memorize one anchor triad - 7% weight loss, 150 minutes/week, ~58% risk reduction - and pair it with the rule that intensive lifestyle is first-line for prediabetes while metformin is reserved for higher-risk groups (e.g., BMI ≥35, age <60, prior GDM, or A1c in the upper prediabetes range).

Picking the 'most potent A1c-lowering' drug on glycemic-efficacy items while ignoring the patient's heart failure, ASCVD, CKD stage, or hypoglycemia risk, and failing to deintensify therapy when A1c falls well below target in an older adult.

Study habits reward memorizing A1c-reduction percentages per class, so candidates answer the efficacy question that was drilled rather than the individualization question actually being asked.

What to do instead

Before answering any drug item, write the patient's three comorbidities and eGFR at the top of your scratch paper; then map: ASCVD/HF/CKD → SGLT2 inhibitor or GLP-1 RA with proven benefit, hypoglycemia risk → avoid sulfonylurea/insulin first, and A1c below target with hypoglycemia risk → reduce rather than maintain.

Continuing metformin at any eGFR, starting an SGLT2 inhibitor without checking volume status or ketone risk, or adjusting insulin without a stated correction factor and basal-to-bolus logic.

Thresholds and titration rules are numeric and easy to blur (eGFR 45 vs 30, hold-before-contrast rules, correction dose formulas), and candidates often answer the 'what drug' question while skipping the 'at what dose, at what eGFR' step.

What to do instead

Create a safety flashcard set: metformin - do not initiate below eGFR 45, stop below 30 and hold for contrast/illness; SGLT2 inhibitor - expect a small early eGFR dip, hold during acute illness; insulin - total daily dose, 50/50 basal-bolus split, correction = (current − target glucose) ÷ insulin sensitivity factor. Recite the numbers aloud before exam day.

Counseling 'avoid sugar and cut carbs' as the nutrition answer, or selecting the plate method for a patient who needs carbohydrate counting and pairing carbohydrate foods with protein/fat without any portion quantification.

Media-driven 'diabetic diet' myths are so familiar that they feel like the safe answer, and candidates under-use the specific counseling frameworks (plate method, carb counting, glycemic index limits) that the exam actually tests.

What to do instead

Replace any answer containing 'avoid' or 'never' with an answer that specifies method, portion, and individualized macronutrient distribution; practice choosing between plate method (low numeracy, new diagnosis) and carb counting (insulin pump/MDI, motivated to fine-tune) based on the learner's numeracy and regimen.

Clearing a patient for a new exercise program without screening for proliferative retinopathy, peripheral neuropathy, autonomic neuropathy, or without planning for hypoglycemia when the patient takes insulin or a sulfonylurea.

Exercise is filed mentally under 'lifestyle, always good', so the contraindication and hypoglycemia-prevention sub-questions get skimmed.

What to do instead

Always run a four-item pre-exercise screen - foot exam and footwear, dilated eye exam status, cardiovascular/autonomic symptoms, and glucose-lowering medication list - then state a concrete hypoglycemia plan (pre-exercise glucose check, carbohydrate if below ~100 mg/dL, evening check after vigorous activity).

Answering education items with what the educator should tell the patient rather than describing the technique that verifies learning or elicits the patient's own priorities; skipping teach-back, motivational interviewing, and SMART goal-setting in favor of a knowledge-dump.

Clinical knowledge is over-practiced relative to counseling process, so the instinct is to give the correct information rather than the correct educational method.

What to do instead

When an item asks about an educator's next action, scan for verbs: assess, ask, elicit, reflect, teach-back. Choose those over explain, instruct, tell, or warn. Draft one SMART goal and one teach-back script from memory so the answer pattern is automatic.

Labeling a disengaged patient 'noncompliant' or 'in denial' instead of screening for diabetes distress, depression, or disordered eating, and missing that diabetes distress is a distinct construct requiring different follow-up than major depression.

Behavioral constructs blur together, and the everyday language of adherence pulls candidates toward judgment-laden answer choices.

What to do instead

Learn the discriminator: depression = persistent low mood/anhedonia across life domains for ≥2 weeks; diabetes distress = regimen-specific frustration, fear of complications, felt burden. Both are screened (e.g., PHQ-9, PAID/DDS), and the correct next step is a structured screen or referral, never an attribution about the patient's character.

Misreading CGM reports - treating time in range as if the goal were 'as high as possible', confusing time below range with time in range, or interpreting GMI as a measured A1c.

The numbers sit close together (TIR >70%, TBR <4% below 70 mg/dL, <1% below 54 mg/dL; GMI correlates with but does not equal A1c) and candidates skim the report instead of reading the thresholds.

What to do instead

Memorize the consensus pentagon once: >70% in 70–180, <4% below 70, <1% below 54, <25% above 180, <5% above 250, with GMI as an estimate of A1c derived from mean glucose. Practice reading three sample AGPs and stating the single highest-priority adjustment for each.

Managing sick days by continuing all usual medications, telling the patient to 'eat less and drink fluids', and omitting ketone testing or the rule to hold SGLT2 inhibitors and metformin during acute illness.

Sick-day rules are rarely memorized as a protocol, and the euglycemic DKA presentation of SGLT2 inhibitors contradicts the expectation that DKA means very high glucose.

What to do instead

Fix one sick-day algorithm in memory: never stop insulin (basal insulin is still needed), hold SGLT2 inhibitors and metformin during vomiting/dehydration, check glucose every 4 hours and ketones if glucose is high or the patient is vomiting, and seek care for persistent vomiting, ketones, or glucose above ~250 mg/dL. Add the reminder that DKA on an SGLT2 inhibitor can occur with glucose under 250 mg/dL.

Exam requirements can change. Confirm current details with the exam provider.

CDCES practice

200 questions. Each one lists the choices, the correct answer, and an explanation. With JavaScript, this list opens one question at a time. The checker at the top of this page saves progress in this browser when it is available.

  1. Question 1Diabetes pathophysiology, epidemiology, and prevention

    Type 1 diabetes mellitus is caused by which underlying process?

    1. Autoimmune destruction of pancreatic beta cells Correct answer.
    2. Progressive resistance to insulin action in skeletal muscle
    3. Excess hepatic glucose output driven by cortisol excess
    4. Impaired insulin receptor signaling in adipose tissue

    Explanation

    Type 1 diabetes is a T-cell mediated autoimmune disease that selectively destroys the insulin-producing beta cells, producing absolute insulin deficiency. Defects in insulin action and receptor signaling are features of type 2 disease rather than type 1.

  2. Question 2Diabetes pathophysiology, epidemiology, and prevention

    Which hemoglobin A1C range is classified as prediabetes under ADA criteria?

    1. 4.0% to 5.6%
    2. 5.7% to 6.4% Correct answer.
    3. 7.0% to 7.4%
    4. 6.5% to 6.9%

    Explanation

    ADA defines normal A1C as below 5.7%, prediabetes as 5.7% through 6.4%, and diabetes as 6.5% or higher on a standardized assay. Values from 6.5% upward already meet the diabetes threshold.

  3. Question 3Diabetes pathophysiology, epidemiology, and prevention

    Which fasting plasma glucose value first meets the diagnostic threshold for diabetes?

    1. 100 mg/dL
    2. 140 mg/dL
    3. 126 mg/dL Correct answer.
    4. 110 mg/dL

    Explanation

    A fasting plasma glucose of 126 mg/dL or higher after at least 8 hours of fasting meets ADA criteria for diabetes. Values of 100 to 125 mg/dL indicate impaired fasting glucose.

  4. Question 4Diabetes pathophysiology, epidemiology, and prevention

    In the Diabetes Prevention Program, intensive lifestyle intervention reduced progression to type 2 diabetes by approximately what percentage?

    1. 40%
    2. 58% Correct answer.
    3. 25%
    4. 15%

    Explanation

    The DPP reported a 58% reduction in incident type 2 diabetes with intensive lifestyle intervention, defined as a 7% weight loss plus 150 minutes of activity weekly. Metformin in the same trial produced a 31% reduction.

  5. Question 5Diabetes pathophysiology, epidemiology, and prevention

    ADA standards recommend that routine screening for prediabetes and diabetes in asymptomatic adults begin at what age?

    1. 30 years
    2. 45 years
    3. 35 years Correct answer.
    4. 25 years

    Explanation

    ADA recommends universal screening of asymptomatic adults beginning at age 35, with repeat testing at least every 3 years. Screening earlier or more often is reserved for people with additional risk factors.

  6. Question 6Diabetes pathophysiology, epidemiology, and prevention

    Screening for gestational diabetes is generally performed at which point in pregnancy?

    1. Between 32 and 34 weeks of gestation
    2. At the first prenatal visit for every pregnant person
    3. Between 12 and 16 weeks of gestation
    4. Between 24 and 28 weeks of gestation Correct answer.

    Explanation

    Universal screening for gestational diabetes is performed at 24 to 28 weeks, when insulin resistance of pregnancy is well established. Early testing is reserved for people with risk factors such as prior gestational diabetes or obesity.

  7. Question 7Diabetes pathophysiology, epidemiology, and prevention

    Type 2 diabetes develops as a result of which combination of abnormalities?

    1. A single insulin receptor mutation in the majority of cases
    2. Insulin resistance plus progressive beta-cell failure Correct answer.
    3. Isolated glucagon deficiency with normal insulin action
    4. Autoimmune beta-cell loss with normal insulin sensitivity

    Explanation

    Type 2 diabetes requires both resistance to insulin action in muscle, liver, and adipose tissue and a failure of beta cells to sustain the compensatory insulin output needed. Hyperglycemia appears once secretion can no longer match demand.

  8. Question 8Diabetes pathophysiology, epidemiology, and prevention

    Which US racial or ethnic group has the highest prevalence of diagnosed diabetes?

    1. American Indian and Alaska Native adults Correct answer.
    2. Non-Hispanic White adults
    3. Hispanic adults
    4. Non-Hispanic Asian adults

    Explanation

    National surveillance consistently shows the highest diagnosed diabetes prevalence among American Indian and Alaska Native adults. Prevalence is also elevated in non-Hispanic Black and Hispanic adults relative to non-Hispanic White adults.

  9. Question 9Diabetes pathophysiology, epidemiology, and prevention

    A patient with long-standing type 1 diabetes has a plasma C-peptide level below the limit of detection. What does this finding indicate?

    1. The patient's injected insulin dose is excessive
    2. Endogenous insulin secretion is minimal to absent Correct answer.
    3. The liver is failing to clear circulating insulin
    4. Insulin antibodies are interfering with the assay

    Explanation

    C-peptide is released in equimolar amounts with endogenous insulin and is absent from exogenous insulin products. An undetectable level therefore reflects little or no residual beta-cell insulin output.

  10. Question 10Diabetes pathophysiology, epidemiology, and prevention

    A lean 45-year-old woman is diagnosed with diabetes, develops ketosis within months, and tests positive for GAD65 antibodies. Which diagnosis fits best?

    1. MODY
    2. Latent autoimmune diabetes in adults Correct answer.
    3. Steroid-induced diabetes
    4. Classic type 2 diabetes

    Explanation

    Latent autoimmune diabetes in adults is characterized by slow autoimmune beta-cell destruction in an adult who may not be obese, with islet autoantibodies and eventual insulin dependence. Positive GAD65 antibodies with rapid progression to ketosis support this diagnosis.

  11. Question 11Diabetes pathophysiology, epidemiology, and prevention

    Velvety, hyperpigmented thickening of the skin at the neck and axillae in a patient with obesity most directly suggests which underlying condition?

    1. Iron overload
    2. Reduced growth hormone secretion
    3. Insulin resistance Correct answer.
    4. Pancreatic exocrine insufficiency

    Explanation

    Acanthosis nigricans results from high circulating insulin stimulating insulin-like growth factor receptors in keratinocytes. It is a clinical marker of insulin resistance and elevated risk for type 2 diabetes.

  12. Question 12Diabetes pathophysiology, epidemiology, and prevention

    In the Diabetes Prevention Program, metformin reduced progression to type 2 diabetes by approximately what percentage?

    1. 45%
    2. 31% Correct answer.
    3. 15%
    4. 8%

    Explanation

    Metformin 850 mg twice daily lowered incident type 2 diabetes by about 31% in the DPP. This was meaningful but smaller than the 58% reduction achieved with intensive lifestyle intervention.

  13. Question 13Diabetes pathophysiology, epidemiology, and prevention

    Impaired glucose tolerance is defined by which 2-hour plasma glucose value during a 75-g oral glucose tolerance test?

    1. 140 to 199 mg/dL Correct answer.
    2. 100 to 125 mg/dL
    3. 200 mg/dL or higher
    4. 126 to 139 mg/dL

    Explanation

    A 2-hour oral glucose tolerance test value of 140 to 199 mg/dL defines impaired glucose tolerance. A value of 200 mg/dL or higher is diagnostic of diabetes.

  14. Question 14Diabetes pathophysiology, epidemiology, and prevention

    A man reports polyuria and polydipsia, and a random plasma glucose is 236 mg/dL. What is the correct interpretation?

    1. The result requires a repeat oral glucose tolerance test before diagnosis
    2. The result suggests prediabetes and requires an A1C for confirmation
    3. Diagnostic of diabetes; no confirmatory test needed Correct answer.
    4. The result is nondiagnostic without a fasting sample

    Explanation

    A random plasma glucose of 200 mg/dL or higher accompanied by classic hyperglycemic symptoms is diagnostic of diabetes. Confirmatory testing is unnecessary when both the symptom picture and the glucose value are present.

  15. Question 15Diabetes pathophysiology, epidemiology, and prevention

    Approximately what fraction of US adults meets criteria for prediabetes?

    1. One in three Correct answer.
    2. One in twenty
    3. One in five
    4. One in ten

    Explanation

    National estimates indicate that roughly one in three US adults, about 38%, has prediabetes, and most are unaware of it. This large pool drives the emphasis on community-level screening and prevention programs.

  16. Question 16Diabetes pathophysiology, epidemiology, and prevention

    A woman who had gestational diabetes has what approximate risk of developing type 2 diabetes within 10 years after delivery?

    1. About 50% Correct answer.
    2. About 90%
    3. About 15%
    4. About 5%

    Explanation

    Roughly half of people with gestational diabetes develop type 2 diabetes within about 10 years. For this reason, ADA recommends lifelong testing for dysglycemia at least every 1 to 3 years.

  17. Question 17Diabetes pathophysiology, epidemiology, and prevention

    In early insulin resistance, fasting glucose often remains close to normal because:

    1. Insulin clearance by the liver increases sharply
    2. The kidney reabsorbs less filtered glucose
    3. Beta cells raise insulin output to compensate Correct answer.
    4. Hepatic glucose output falls below normal

    Explanation

    Compensatory hyperinsulinemia keeps glucose in range while beta cells can match the rising demand imposed by insulin resistance. Hyperglycemia emerges only when secretion can no longer keep pace.

  18. Question 18Diabetes pathophysiology, epidemiology, and prevention

    Which mechanism explains the dawn phenomenon in a person with diabetes?

    1. A pre-dawn rise in counterregulatory hormones Correct answer.
    2. Excessive carbohydrate intake at bedtime
    3. Rebound hyperglycemia following an overnight hypoglycemic episode
    4. Delayed absorption of the evening basal insulin dose

    Explanation

    The dawn phenomenon results from nocturnal secretion of growth hormone, cortisol, glucagon, and catecholamines, which increase hepatic glucose output and insulin resistance before waking. It is distinguished from rebound hyperglycemia after nocturnal hypoglycemia, which is the Somogyi effect.

  19. Question 19Diabetes pathophysiology, epidemiology, and prevention

    In poorly controlled diabetes, alpha-cell dysfunction contributes to hyperglycemia by:

    1. Excess glucagon driving hepatic glucose output Correct answer.
    2. Increasing somatostatin release from pancreatic delta cells
    3. Impairing gastric emptying of ingested carbohydrate
    4. Reducing glucagon secretion below the normal range

    Explanation

    Alpha cells in diabetes fail to suppress glucagon appropriately when glucose is high, so hepatic glucose production stays elevated. This defect is a target of incretin-based and other therapies.

  20. Question 20Diabetes pathophysiology, epidemiology, and prevention

    Amylin, which is co-secreted with insulin by beta cells, contributes to postprandial glucose control mainly by:

    1. Stimulating glucagon secretion
    2. Increasing hepatic glucose output
    3. Slowing gastric emptying and promoting fullness Correct answer.
    4. Enhancing renal tubular glucose reabsorption

    Explanation

    Amylin slows gastric emptying, suppresses postprandial glucagon, and increases satiety, which blunts the post-meal glucose rise. The synthetic amylin analog pramlintide is used for this effect.

  21. Question 21Diabetes pathophysiology, epidemiology, and prevention

    Which HLA haplotypes confer the strongest inherited risk for type 1 diabetes?

    1. HLA-DR2-DQ6 and HLA-DR7
    2. HLA-DQ4 and HLA-DQ5
    3. HLA-DR3-DQ2 and HLA-DR4-DQ8 Correct answer.
    4. HLA-B27 and HLA-Cw6

    Explanation

    The DR3-DQ2 and DR4-DQ8 haplotypes, particularly when both are present, account for the largest share of type 1 diabetes susceptibility. Other HLA types listed are associated with different autoimmune conditions or are neutral for diabetes.

  22. Question 22Diabetes pathophysiology, epidemiology, and prevention

    A child has type 1 diabetes. What is the approximate risk that a sibling will also develop type 1 diabetes?

    1. About 25%
    2. About 6% Correct answer.
    3. About 0.4%
    4. About 50%

    Explanation

    Sibling recurrence risk is roughly 6%, compared with about 0.4% in the general population, reflecting shared HLA susceptibility. This elevated risk is why family members may be offered islet autoantibody screening in research and some clinical settings.

  23. Question 23Diabetes pathophysiology, epidemiology, and prevention

    A 40-year-old African American man with obesity presents in ketoacidosis, but islet autoantibodies are negative and he later maintains near-normoglycemia without insulin. Which entity is most likely?

    1. Type 3c pancreatogenic diabetes
    2. Ketosis-prone type 2 diabetes Correct answer.
    3. Classic type 1 diabetes
    4. MODY

    Explanation

    Ketosis-prone, or Flatbush, diabetes presents with diabetic ketoacidosis but lacks islet autoantibodies, and many patients regain enough beta-cell function to discontinue insulin. It is most often seen in people of African or Hispanic ancestry.

  24. Question 24Diabetes pathophysiology, epidemiology, and prevention

    A 22-year-old has a lifelong fasting glucose of 108 to 115 mg/dL, an A1C of 6.2%, no obesity, and a parent with the same pattern. Which statement about GCK-MODY is correct?

    1. Stable mild fasting hyperglycemia; usually no treatment Correct answer.
    2. It is inherited in an autosomal recessive pattern
    3. Microvascular complications develop in most affected adults
    4. Basal insulin is required for most affected patients

    Explanation

    A glucokinase mutation raises the beta-cell glucose set point, producing mild, stable fasting hyperglycemia from birth with a low risk of complications. Pharmacologic treatment rarely alters outcomes, so many affected people need no medication.

  25. Question 25Diabetes pathophysiology, epidemiology, and prevention

    Diabetes developing after repeated attacks of chronic pancreatitis with exocrine insufficiency is best classified as:

    1. Secondary diabetes from glucocorticoid therapy
    2. Type 2 diabetes driven primarily by obesity
    3. Type 1 diabetes from autoimmune beta-cell loss
    4. Pancreatogenic (type 3c) diabetes Correct answer.

    Explanation

    Pancreatogenic diabetes results from destruction of both exocrine and endocrine pancreatic tissue by pancreatitis, trauma, or pancreatectomy. Management often combines insulin with pancreatic enzyme replacement because glucagon and incretin responses are also impaired.

  26. Question 26Diabetes pathophysiology, epidemiology, and prevention

    In a nonpregnant adult, which hemoglobin A1C value meets the diagnostic threshold for diabetes?

    1. 6.5% or higher Correct answer.
    2. 5.7% to 6.4%
    3. 6.0% or higher
    4. 7.0% or higher

    Explanation

    A1C reflects about 2 to 3 months of average glycemia, and a value of 6.5% or greater is one accepted criterion for diagnosing diabetes. Values below 6.5% fall into the normal or prediabetes ranges unless another criterion is met.

  27. Question 27Diabetes pathophysiology, epidemiology, and prevention

    A fasting plasma glucose at or above which value satisfies a diagnostic criterion for diabetes?

    1. 100 mg/dL
    2. 140 mg/dL
    3. 110 mg/dL
    4. 126 mg/dL Correct answer.

    Explanation

    Fasting plasma glucose of 126 mg/dL or higher, confirmed on a second occasion in an asymptomatic person, establishes diabetes. Fasting values between 100 and 125 mg/dL represent impaired fasting glucose.

  28. Question 28Diabetes pathophysiology, epidemiology, and prevention

    Which A1C range defines prediabetes in a nonpregnant adult?

    1. 5.0% to 6.0%
    2. 4.0% to 5.6%
    3. 5.7% to 6.4% Correct answer.
    4. 6.5% to 7.0%

    Explanation

    An A1C of 5.7% to 6.4% identifies prediabetes and signals increased risk for progression to type 2 diabetes. Values below 5.7% are normal and values of 6.5% or higher meet the diabetes threshold.

  29. Question 29Diabetes pathophysiology, epidemiology, and prevention

    Type 1 diabetes accounts for approximately what share of all diabetes cases?

    1. 20% to 25%
    2. 35% to 40%
    3. 5% to 10% Correct answer.
    4. 50% to 60%

    Explanation

    Type 1 diabetes is the minority of cases, generally estimated at roughly 5% to 10% of all diabetes worldwide. Type 2 diabetes accounts for the large majority, with gestational and other specific types making up the remainder.

  30. Question 30Diabetes pathophysiology, epidemiology, and prevention

    The incretin defect described in type 2 diabetes refers to which finding?

    1. Enhanced suppression of glucagon after meals
    2. Excess GLP-1 secretion after meals
    3. Heightened sensitivity to gastric inhibitory polypeptide
    4. Blunted postprandial GLP-1 effect Correct answer.

    Explanation

    Orally ingested glucose normally provokes a larger insulin response than intravenous glucose because of incretin hormones. In type 2 diabetes the insulinotropic action of GLP-1 after meals is diminished, which contributes to postprandial hyperglycemia.

  31. Question 31Diabetes pathophysiology, epidemiology, and prevention

    In the Diabetes Prevention Program, the intensive lifestyle intervention reduced progression to type 2 diabetes by approximately what percentage?

    1. 58% Correct answer.
    2. 72%
    3. 20%
    4. 31%

    Explanation

    The intensive lifestyle arm of the Diabetes Prevention Program lowered the incidence of type 2 diabetes by about 58% over roughly three years. This exceeded the reduction seen with metformin, which was about 31%.

  32. Question 32Diabetes pathophysiology, epidemiology, and prevention

    The intensive lifestyle arm of the Diabetes Prevention Program targeted which combination of weight loss and physical activity?

    1. 15% weight loss and 200 minutes of activity per week
    2. 10% weight loss and 300 minutes of activity per week
    3. 5% weight loss and 90 minutes of activity per week
    4. 7% weight loss and 150 minutes of activity per week Correct answer.

    Explanation

    The program aimed for at least 7% loss of initial body weight plus 150 minutes per week of moderate-intensity activity such as brisk walking. These goals are the basis for current lifestyle recommendations for diabetes prevention.

  33. Question 33Diabetes pathophysiology, epidemiology, and prevention

    Approximately what proportion of US adults who have diabetes are undiagnosed?

    1. 1 in 10
    2. 1 in 5 Correct answer.
    3. 1 in 20
    4. 1 in 2

    Explanation

    National survey data indicate that roughly one in five adults with diabetes has not received a diagnosis, in part because type 2 diabetes can be asymptomatic for years. Undiagnosed disease contributes to complications present at the time of diagnosis.

  34. Question 34Diabetes pathophysiology, epidemiology, and prevention

    Insulin resistance rises substantially in the second and third trimesters of pregnancy primarily because of which change?

    1. Higher maternal insulin sensitivity
    2. A fall in maternal cortisol levels
    3. Increased maternal activity
    4. Placental hormone secretion Correct answer.

    Explanation

    The placenta secretes hormones including human placental lactogen, progesterone, and cortisol, which progressively blunt maternal insulin action. When beta cells cannot compensate for this resistance, gestational diabetes develops.

  35. Question 35Diabetes pathophysiology, epidemiology, and prevention

    Elevated fasting glucose in type 2 diabetes is driven mainly by which abnormality?

    1. Increased hepatic glucose output Correct answer.
    2. Reduced glucagon secretion by alpha cells
    3. Delayed emptying of the stomach after meals
    4. Enhanced insulin sensitivity in muscle

    Explanation

    Hepatic insulin resistance and inadequate insulin suppression of the liver cause inappropriately high glucose release overnight and in the fasting state. This excess hepatic output is a principal determinant of the fasting glucose level.

  36. Question 36Diabetes pathophysiology, epidemiology, and prevention

    Which adipose-derived hormone is reduced in obesity and correlates positively with insulin sensitivity?

    1. Leptin
    2. Adiponectin Correct answer.
    3. Resistin
    4. Tumor necrosis factor-alpha

    Explanation

    Adiponectin is an insulin-sensitizing adipokine whose circulating levels fall with increasing visceral adiposity. Low adiponectin is associated with insulin resistance and higher risk of type 2 diabetes.

  37. Question 37Diabetes pathophysiology, epidemiology, and prevention

    In the accepted staging of type 1 diabetes, stage 1 is characterized by which finding?

    1. Normoglycemia with no autoantibodies but a susceptible HLA type
    2. Normoglycemia with two or more islet autoantibodies Correct answer.
    3. Symptomatic hyperglycemia with a single islet autoantibody
    4. Fasting glucose of 126 mg/dL or higher together with two autoantibodies

    Explanation

    Stage 1 describes beta-cell autoimmunity, evidenced by two or more islet autoantibodies, in a person who still has normal glucose tolerance. Dysglycemia marks stage 2 and clinical symptoms mark stage 3.

  38. Question 38Diabetes pathophysiology, epidemiology, and prevention

    Long-term follow-up in the UK Prospective Diabetes Study showed that beta-cell function in type 2 diabetes typically does what after diagnosis?

    1. Remains stable when glucose is well controlled
    2. Declines progressively over the years Correct answer.
    3. Recovers fully with sustained weight loss
    4. Improves during sulfonylurea therapy

    Explanation

    Serial measures in that cohort demonstrated a steady loss of beta-cell function over time regardless of the treatment assigned. This progressive decline underlies the need to intensify therapy as diabetes duration increases.

  39. Question 39Diabetes pathophysiology, epidemiology, and prevention

    Type 2 diabetes develops at a lower BMI in South Asian populations than in European populations largely because of which factor?

    1. Lower levels of physical inactivity in this group
    2. Higher skeletal muscle mass at any given BMI
    3. Slower rates of urban migration and aging
    4. More visceral fat and lower beta-cell reserve Correct answer.

    Explanation

    At comparable BMI, South Asian adults tend to carry more visceral and ectopic fat and to have less compensatory beta-cell capacity, so dysglycemia appears at a lower body weight. This is why lower BMI screening thresholds are recommended for this group.

  40. Question 40Diabetes pathophysiology, epidemiology, and prevention

    Current ADA guidance recommends that routine screening for prediabetes and type 2 diabetes begin at what age in adults without risk factors?

    1. 18 years
    2. 35 years Correct answer.
    3. 45 years
    4. 25 years

    Explanation

    Screening is recommended to begin at age 35 for adults without other risk factors and to repeat at least every three years. Earlier or more frequent testing is advised when risk factors such as obesity or prior gestational diabetes are present.

  41. Question 41Clinical management: pharmacotherapy and glycemic targets

    For most nonpregnant adults with type 2 diabetes who have no significant hypoglycemia, what is the recommended A1C target?

    1. <6.0%
    2. <6.5%
    3. <8.0%
    4. <7.0% Correct answer.

    Explanation

    The American Diabetes Association recommends an A1C goal of less than 7% for most nonpregnant adults with diabetes. More stringent goals may be appropriate when they can be achieved safely without hypoglycemia, while less stringent goals are used for limited life expectancy or high hypoglycemia risk.

  42. Question 42Clinical management: pharmacotherapy and glycemic targets

    Which medication is recommended as initial pharmacotherapy for a newly diagnosed patient with type 2 diabetes and no contraindications?

    1. Sitagliptin
    2. Insulin glargine
    3. Glipizide
    4. Metformin Correct answer.

    Explanation

    Metformin is the usual first-line medication for type 2 diabetes unless it is contraindicated or not tolerated. It is effective, has a low risk of hypoglycemia when used alone, and is affordable.

  43. Question 43Clinical management: pharmacotherapy and glycemic targets

    A conscious adult with diabetes has a blood glucose of 58 mg/dL and can swallow. What is the appropriate initial treatment?

    1. 10 g carbohydrate, recheck in 10 min
    2. 5 g carbohydrate, recheck in 5 min
    3. 15 g carbohydrate, recheck in 15 min Correct answer.
    4. 30 g carbohydrate, recheck in 30 minutes

    Explanation

    The rule of 15 is to give 15 g of fast-acting carbohydrate and recheck the glucose in 15 minutes. If the glucose remains low, the treatment is repeated before a meal or snack is provided.

  44. Question 44Clinical management: pharmacotherapy and glycemic targets

    Which insulin has the most rapid onset of action?

    1. Insulin glargine
    2. NPH insulin
    3. Insulin lispro Correct answer.
    4. Regular insulin

    Explanation

    Insulin lispro is a rapid-acting analog that begins working within about 15 minutes. Regular insulin is short acting, NPH is intermediate acting, and glargine is long acting.

  45. Question 45Clinical management: pharmacotherapy and glycemic targets

    Which finding is a contraindication to initiating a GLP-1 receptor agonist?

    1. Personal history of medullary thyroid cancer Correct answer.
    2. History of acute pancreatitis
    3. Concurrent use of a sulfonylurea with insulin
    4. eGFR of 45 mL/min/1.73 m2

    Explanation

    GLP-1 receptor agonists carry a boxed warning and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. A history of pancreatitis is a caution, and renal impairment requires dose selection rather than absolute avoidance.

  46. Question 46Clinical management: pharmacotherapy and glycemic targets

    Which adverse effect is most characteristic of SGLT2 inhibitors when used as monotherapy?

    1. Weight gain of more than 5 kg
    2. Genital mycotic infection Correct answer.
    3. Severe hypoglycemia requiring assistance
    4. Sinus bradycardia with exercise

    Explanation

    SGLT2 inhibitors increase urinary glucose excretion, which promotes genital mycotic infections. Hypoglycemia is uncommon with monotherapy, and these agents typically cause modest weight loss rather than weight gain.

  47. Question 47Clinical management: pharmacotherapy and glycemic targets

    Metformin is contraindicated in patients with which eGFR?

    1. Below 30 mL/min/1.73 m2 Correct answer.
    2. Below 15 mL/min/1.73 m2
    3. Below 60 mL/min/1.73 m2
    4. Below 45 mL/min/1.73 m2

    Explanation

    Metformin is contraindicated when the eGFR is below 30 mL/min/1.73 m2 because of the risk of lactic acidosis. Initiating metformin is also not recommended at an eGFR of 30 to 45 mL/min/1.73 m2.

  48. Question 48Clinical management: pharmacotherapy and glycemic targets

    When titrating basal insulin in a patient with type 2 diabetes, which fasting glucose range is a common target?

    1. 70-100 mg/dL
    2. 140-180 mg/dL
    3. 100-150 mg/dL
    4. 80-130 mg/dL Correct answer.

    Explanation

    A common fasting glucose target during basal insulin titration is 80 to 130 mg/dL. Basal insulin is adjusted to bring fasting glucose into this range while avoiding nocturnal hypoglycemia.

  49. Question 49Clinical management: pharmacotherapy and glycemic targets

    An 82-year-old with dementia, end-stage renal disease, and recurrent severe hypoglycemia has an A1C of 8.1%. Which A1C target is most appropriate?

    1. <7.0%
    2. <6.5%
    3. <8.0% Correct answer.
    4. <7.5%

    Explanation

    A less stringent A1C goal, such as less than 8.0%, is appropriate for patients with limited life expectancy, advanced complications, multiple comorbidities, or high hypoglycemia risk. The goal should prioritize safety and avoidance of symptomatic hypoglycemia.

  50. Question 50Clinical management: pharmacotherapy and glycemic targets

    A patient with type 2 diabetes takes metformin and basal insulin 0.5 units/kg. Fasting glucose is 110-125 mg/dL, but A1C remains 8.4%. What is the best next step?

    1. Increase the basal insulin dose by 20%
    2. Discontinue basal insulin and start pioglitazone
    3. Add prandial insulin or GLP-1 agonist Correct answer.
    4. Add a sulfonylurea

    Explanation

    When fasting glucose is at goal but A1C remains above target, postprandial hyperglycemia is the likely contributor. Adding prandial insulin or a GLP-1 receptor agonist addresses postprandial excursions without excessive basal insulin increases.

  51. Question 51Clinical management: pharmacotherapy and glycemic targets

    What is the mechanism of action of sulfonylureas?

    1. Close ATP-sensitive potassium channels Correct answer.
    2. Increase insulin sensitivity in muscle
    3. Reduce hepatic glucose production by activating AMP kinase
    4. Inhibit DPP-4 and prolong incretin activity

    Explanation

    Sulfonylureas stimulate insulin secretion by closing ATP-sensitive potassium channels on pancreatic beta cells. This depolarizes the beta cell and triggers insulin release.

  52. Question 52Clinical management: pharmacotherapy and glycemic targets

    Why is combining a DPP-4 inhibitor with a GLP-1 receptor agonist generally not recommended?

    1. They cause serotonin syndrome
    2. They neutralize each other's glucose-lowering effect
    3. Both are contraindicated in chronic kidney disease
    4. They share an incretin pathway and add little benefit Correct answer.

    Explanation

    DPP-4 inhibitors and GLP-1 receptor agonists both enhance incretin signaling, so combining them provides little additional glucose lowering. The combination also adds cost and potential adverse effects without meaningful benefit.

  53. Question 53Clinical management: pharmacotherapy and glycemic targets

    A 62-year-old with type 2 diabetes, heart failure with reduced ejection fraction, and eGFR 35 mL/min/1.73 m2 has an A1C of 7.8%. Which class has proven benefit for heart failure and kidney outcomes?

    1. Sulfonylureas
    2. DPP-4 inhibitors
    3. Thiazolidinediones
    4. SGLT2 inhibitors Correct answer.

    Explanation

    SGLT2 inhibitors reduce heart failure hospitalization and slow chronic kidney disease progression in patients with type 2 diabetes. They are recommended in heart failure with reduced ejection fraction and in chronic kidney disease.

  54. Question 54Clinical management: pharmacotherapy and glycemic targets

    Which adverse effect requires monitoring in a patient starting pioglitazone?

    1. Genital mycotic infections and dysuria
    2. Fluid retention and heart failure Correct answer.
    3. Medullary thyroid carcinoma risk
    4. Lactic acidosis

    Explanation

    Thiazolidinediones such as pioglitazone cause fluid retention, weight gain, and edema and can precipitate or worsen heart failure. They are contraindicated in severe heart failure.

  55. Question 55Clinical management: pharmacotherapy and glycemic targets

    A patient uses 40 units of insulin daily. Using the 1800 rule, what is the estimated correction factor?

    1. 20 mg/dL per unit
    2. 45 mg/dL per unit Correct answer.
    3. 30 mg/dL per unit
    4. 60 mg/dL per unit

    Explanation

    The 1800 rule estimates the correction factor by dividing 1800 by the total daily insulin dose. For a total daily dose of 40 units, 1800 divided by 40 equals 45 mg/dL per unit.

  56. Question 56Clinical management: pharmacotherapy and glycemic targets

    A patient uses 50 units of insulin daily. Using the 500 rule, what is the estimated insulin-to-carbohydrate ratio?

    1. 20 g per unit
    2. 10 g per unit Correct answer.
    3. 5 g per unit
    4. 15 g per unit

    Explanation

    The 500 rule estimates the insulin-to-carbohydrate ratio by dividing 500 by the total daily insulin dose. For 50 units daily, 500 divided by 50 equals 10 g of carbohydrate per unit of insulin.

  57. Question 57Clinical management: pharmacotherapy and glycemic targets

    A newly diagnosed patient with type 2 diabetes has an eGFR of 38 mL/min/1.73 m2. What is the most appropriate action regarding metformin?

    1. Start metformin 1000 mg twice daily
    2. Avoid initiating metformin Correct answer.
    3. Start metformin 500 mg twice daily
    4. Start metformin extended release at a high dose

    Explanation

    Metformin should not be initiated when the eGFR is 30 to 45 mL/min/1.73 m2 because of increased lactic acidosis risk. If a patient is already taking metformin in this range, the risk-benefit balance should be reassessed and the dose may need reduction.

  58. Question 58Clinical management: pharmacotherapy and glycemic targets

    A patient starting semaglutide reports nausea and vomiting. What is the best initial management?

    1. Slow titration and use a lower maintenance dose Correct answer.
    2. Stop the medication permanently
    3. Add a daily antiemetic and continue doubling the dose
    4. Take the next dose with a high-fat meal

    Explanation

    Gastrointestinal effects are common with GLP-1 receptor agonists and are reduced by starting at a low dose and titrating slowly. A lower maintenance dose may be used if symptoms persist.

  59. Question 59Clinical management: pharmacotherapy and glycemic targets

    A patient with type 1 diabetes who takes propranolol develops hypoglycemia. Which warning symptom is most likely to be masked?

    1. Sweating, which is a cholinergic response
    2. Tremor and palpitations Correct answer.
    3. Hunger, which is mediated by the hypothalamus
    4. Confusion, which reflects neuroglycopenia

    Explanation

    Beta-blockers blunt the adrenergic warning symptoms of hypoglycemia, including tremor, palpitations, and anxiety. Sweating is mediated by cholinergic pathways and is often preserved.

  60. Question 60Clinical management: pharmacotherapy and glycemic targets

    A patient with type 2 diabetes takes prednisone 40 mg every morning. Fasting glucose is normal but glucose after lunch and dinner is 250-300 mg/dL. What is the best pharmacologic adjustment?

    1. Add bedtime metformin and recheck in a week
    2. Add prandial insulin at lunch Correct answer.
    3. Increase the basal insulin dose substantially
    4. Stop prednisone abruptly

    Explanation

    Glucocorticoids typically cause postprandial and afternoon-to-evening hyperglycemia while fasting glucose may remain normal. Prandial insulin at lunch, or morning NPH in some regimens, targets this pattern.

  61. Question 61Clinical management: pharmacotherapy and glycemic targets

    Which laboratory finding favors hyperosmolar hyperglycemic state over diabetic ketoacidosis?

    1. Serum osmolality of 330 mOsm/kg Correct answer.
    2. Bicarbonate of 10 mEq/L with a normal glucose
    3. Arterial pH of 7.10 with a normal osmolarity
    4. Large serum ketones with a normal anion gap

    Explanation

    Hyperosmolar hyperglycemic state is characterized by marked hyperglycemia, serum osmolality greater than 320 mOsm/kg, profound dehydration, and minimal ketosis. Diabetic ketoacidosis is characterized by acidosis and ketone accumulation.

  62. Question 62Clinical management: pharmacotherapy and glycemic targets

    A patient taking empagliflozin is scheduled for elective surgery. What is the recommended perioperative management?

    1. Continue empagliflozin until the morning of surgery
    2. Stop empagliflozin 1 day before surgery
    3. Stop empagliflozin 3 days before surgery Correct answer.
    4. No change is needed because glucose is normal

    Explanation

    SGLT2 inhibitors can cause euglycemic diabetic ketoacidosis, so they are typically stopped about 3 days before elective surgery. Normal glucose does not exclude ketosis risk.

  63. Question 63Clinical management: pharmacotherapy and glycemic targets

    Which medication should be avoided in a patient with severe diabetic gastroparesis?

    1. A GLP-1 receptor agonist Correct answer.
    2. A thiazolidinedione such as pioglitazone
    3. A DPP-4 inhibitor such as sitagliptin
    4. An SGLT2 inhibitor such as empagliflozin

    Explanation

    GLP-1 receptor agonists slow gastric emptying and can worsen nausea, vomiting, and early satiety in patients with gastroparesis. They should be avoided or used with caution in severe gastroparesis.

  64. Question 64Clinical management: pharmacotherapy and glycemic targets

    What is the recommended A1C target during pregnancy for a patient with preexisting type 1 diabetes, if it can be achieved without hypoglycemia?

    1. <6.0% Correct answer.
    2. <7.0%
    3. <6.5%
    4. <5.5%

    Explanation

    The American Diabetes Association recommends an A1C goal of less than 6.0% during pregnancy if it can be achieved without hypoglycemia. Lower targets increase the risk of maternal hypoglycemia.

  65. Question 65Clinical management: pharmacotherapy and glycemic targets

    Which two glucose-lowering medications should generally not be combined because they share the same mechanism?

    1. Glyburide and repaglinide Correct answer.
    2. Empagliflozin and metformin
    3. Metformin and sitagliptin
    4. Basal insulin and a GLP-1 receptor agonist

    Explanation

    Sulfonylureas and meglitinides both stimulate insulin secretion by acting on pancreatic beta cells. Combining them adds little benefit and increases the risk of hypoglycemia and weight gain.

  66. Question 66Clinical management: pharmacotherapy and glycemic targets

    What is the general A1C target for most nonpregnant adults with diabetes who do not have significant comorbidities?

    1. <7.0% Correct answer.
    2. <9.0%
    3. <8.0%
    4. <6.0%

    Explanation

    For most nonpregnant adults with diabetes, an A1C goal of <7.0% is recommended when it can be achieved without significant hypoglycemia or other adverse effects. Targets should be individualized based on comorbidities, life expectancy, and patient preference.

  67. Question 67Clinical management: pharmacotherapy and glycemic targets

    When initiating basal insulin in an adult with type 2 diabetes, which starting dose is most commonly recommended?

    1. 10 units/day or 0.1 to 0.2 units/kg/day Correct answer.
    2. 0.5 units/kg/day
    3. 1 unit/kg/day
    4. 4 units four times daily

    Explanation

    Basal insulin is typically started at 10 units per day or 0.1 to 0.2 units/kg/day and then titrated based on fasting glucose. Higher starting doses increase the risk of hypoglycemia.

  68. Question 68Clinical management: pharmacotherapy and glycemic targets

    A patient reports mild nausea and diarrhea after starting metformin. What is the most appropriate initial management?

    1. Take metformin with meals and consider switching to extended-release Correct answer.
    2. Stop metformin permanently
    3. Double the metformin dose
    4. Add a sulfonylurea

    Explanation

    Gastrointestinal effects are common with metformin and often improve when the drug is taken with meals or when the extended-release formulation is used. Dose titration also helps limit these effects.

  69. Question 69Clinical management: pharmacotherapy and glycemic targets

    A conscious patient with diabetes has a capillary glucose of 55 mg/dL and can swallow. What is the best initial treatment?

    1. Give 15 g of fast-acting carbohydrate and recheck in 15 minutes Correct answer.
    2. Give 1 unit of rapid-acting insulin
    3. Give 30 g of carbohydrate immediately
    4. Give a high-protein snack only

    Explanation

    Hypoglycemia in a conscious patient who can swallow is treated with the 15-15 rule: 15 g of fast-acting carbohydrate, followed by a glucose recheck in 15 minutes and repeat treatment if still low. Protein alone does not raise glucose quickly enough.

  70. Question 70Clinical management: pharmacotherapy and glycemic targets

    Which history is a contraindication to initiating a GLP-1 receptor agonist?

    1. History of seasonal allergies
    2. Personal or family history of medullary thyroid carcinoma Correct answer.
    3. History of hypertension
    4. History of type 2 diabetes for 10 years

    Explanation

    GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. A long duration of diabetes, hypertension, and seasonal allergies are not contraindications.

  71. Question 71Clinical management: pharmacotherapy and glycemic targets

    A patient uses insulin aspart before meals. When should the injection usually be given relative to the meal?

    1. 45 to 60 minutes before the meal
    2. 0 to 15 minutes before the meal Correct answer.
    3. 60 minutes after the meal
    4. Only at bedtime

    Explanation

    Rapid-acting insulin analogs such as aspart and lispro begin to act within about 15 minutes and are usually injected 0 to 15 minutes before a meal. If premeal glucose is low, the dose may be given after the meal.

  72. Question 72Clinical management: pharmacotherapy and glycemic targets

    A patient with type 2 diabetes and a history of heart failure is started on a DPP-4 inhibitor. Which DPP-4 inhibitor has been associated with an increased risk of heart failure hospitalization and should generally be avoided in this setting?

    1. Sitagliptin
    2. Saxagliptin Correct answer.
    3. Linagliptin
    4. Metformin

    Explanation

    Saxagliptin has been associated with an increased risk of heart failure hospitalization in patients with heart failure and is generally avoided in this population. Sitagliptin and linagliptin have not shown this signal.

  73. Question 73Clinical management: pharmacotherapy and glycemic targets

    Pioglitazone should be avoided in which condition?

    1. Stage 2 chronic kidney disease
    2. Mild asthma
    3. Osteoarthritis
    4. NYHA class III heart failure Correct answer.

    Explanation

    Thiazolidinediones such as pioglitazone cause fluid retention and are contraindicated in NYHA class III or IV heart failure. They should also be used cautiously in patients at risk for heart failure.

  74. Question 74Clinical management: pharmacotherapy and glycemic targets

    Which laboratory monitoring is recommended for a patient on long-term metformin therapy?

    1. Weekly complete blood count
    2. Daily urine ketones
    3. Periodic vitamin B12 measurement Correct answer.
    4. Monthly serum calcium

    Explanation

    Long-term metformin use can reduce vitamin B12 absorption, and periodic B12 measurement is recommended, especially in patients with anemia or peripheral neuropathy. Routine calcium, weekly CBC, and daily urine ketones are not standard metformin monitoring.

  75. Question 75Clinical management: pharmacotherapy and glycemic targets

    Which condition can cause a falsely low A1C result?

    1. Chronic kidney disease
    2. Iron deficiency anemia
    3. Hemolytic anemia Correct answer.
    4. Poorly controlled hyperglycemia

    Explanation

    A1C reflects glucose exposure over the lifespan of red blood cells. Conditions that shorten red blood cell survival, such as hemolytic anemia, can falsely lower A1C. Iron deficiency often falsely raises A1C, and hyperglycemia raises it.

  76. Question 76Clinical management: pharmacotherapy and glycemic targets

    A patient has a correction factor of 50 mg/dL per unit, a target glucose of 120 mg/dL, and a current glucose of 270 mg/dL. What is the estimated correction dose of rapid-acting insulin?

    1. 2 units
    2. 1 unit
    3. 5 units
    4. 3 units Correct answer.

    Explanation

    The correction dose is calculated as (current glucose minus target glucose) divided by the correction factor. Here, (270 - 120) / 50 = 3 units.

  77. Question 77Clinical management: pharmacotherapy and glycemic targets

    A patient taking empagliflozin presents with nausea, vomiting, and abdominal pain. Glucose is 210 mg/dL, bicarbonate is 12 mEq/L, and ketones are positive. What is the most appropriate next step?

    1. Evaluate and treat for euglycemic diabetic ketoacidosis Correct answer.
    2. Reassure the patient that glucose is not high enough for ketoacidosis
    3. Stop empagliflozin and give oral fluids at home
    4. Increase the empagliflozin dose

    Explanation

    SGLT2 inhibitors can cause diabetic ketoacidosis with only modest glucose elevation, sometimes called euglycemic DKA. The combination of nausea, vomiting, low bicarbonate, and positive ketones requires urgent evaluation and treatment.

  78. Question 78Clinical management: pharmacotherapy and glycemic targets

    A patient with type 1 diabetes has fasting hyperglycemia. A 3 AM glucose check shows 55 mg/dL. What is the most likely cause and appropriate action?

    1. Somogyi effect; reduce the evening basal insulin dose Correct answer.
    2. Dawn phenomenon; increase the evening basal insulin dose
    3. Rebound hyperglycemia from missed insulin; give an extra bedtime dose
    4. Inadequate prandial insulin; add a pre-breakfast correction dose

    Explanation

    Nocturnal hypoglycemia followed by morning hyperglycemia suggests the Somogyi effect, a rebound phenomenon. Reducing the evening basal insulin dose can prevent the nocturnal low and the subsequent rebound high.

  79. Question 79Clinical management: pharmacotherapy and glycemic targets

    A patient with diabetic ketoacidosis has a serum potassium of 3.1 mEq/L. What is the correct initial approach to insulin therapy?

    1. Give subcutaneous insulin glargine only
    2. Start the insulin infusion immediately at a high rate
    3. Give sodium bicarbonate before insulin
    4. Hold insulin and give intravenous potassium until potassium is above 3.3 mEq/L Correct answer.

    Explanation

    Insulin shifts potassium into cells and can worsen hypokalemia. In DKA, insulin should be held and potassium replaced until the serum potassium is above 3.3 mEq/L.

  80. Question 80Clinical management: pharmacotherapy and glycemic targets

    A patient with type 2 diabetes takes basal insulin 30 units daily and is starting a GLP-1 receptor agonist. Which action best reduces the risk of hypoglycemia?

    1. Consider reducing the basal insulin dose, especially if A1C is near target Correct answer.
    2. Stop all glucose-lowering therapy
    3. Increase the basal insulin dose by 20%
    4. Add a sulfonylurea

    Explanation

    GLP-1 receptor agonists improve glycemia and can increase hypoglycemia risk when combined with insulin or a sulfonylurea. Reducing the basal insulin dose, particularly when A1C is near target, helps lower that risk.

  81. Question 81Nutrition, physical activity, and weight management

    An adult with diabetes has a blood glucose of 58 mg/dL, is alert, and can swallow safely. What is the recommended first action?

    1. Take 30 g of fast-acting carbohydrate and recheck glucose after 30 minutes have passed
    2. Take 15 g of fast-acting carbohydrate and recheck in 15 minutes Correct answer.
    3. Eat a meal containing complex carbohydrate and protein and recheck glucose in 1 hour
    4. Take 5 g of fast-acting carbohydrate and recheck glucose after 5 minutes have passed

    Explanation

    Hypoglycemia in an alert person who can swallow is treated with the 15-15 rule: 15 g of fast-acting carbohydrate, then a glucose recheck in 15 minutes, repeating until glucose is above 70 mg/dL before a meal or snack is eaten. Using a larger initial dose or a mixed meal delays correction and can cause rebound hyperglycemia.

  82. Question 82Nutrition, physical activity, and weight management

    What weekly volume of aerobic activity is recommended for most adults with diabetes?

    1. At least 90 minutes per week of moderate-intensity aerobic activity
    2. At least 60 minutes per week of moderate-intensity aerobic activity
    3. At least 300 minutes per week of vigorous-intensity aerobic exercise
    4. At least 150 minutes per week of moderate-intensity aerobic activity Correct answer.

    Explanation

    Guidelines recommend at least 150 minutes per week of moderate-intensity aerobic activity, spread over at least 3 days with no more than 2 consecutive days without activity. Higher volumes (about 300 minutes per week) are suggested only when weight loss or greater cardiometabolic benefit is a goal.

  83. Question 83Nutrition, physical activity, and weight management

    In the Diabetes Prevention Program, which weight-loss goal was associated with the greatest reduction in progression to type 2 diabetes?

    1. 7% of body weight Correct answer.
    2. 3% of body weight
    3. 5% of body weight
    4. 10% of body weight

    Explanation

    The Diabetes Prevention Program used a lifestyle intervention targeting 7% weight loss plus 150 minutes per week of activity, which reduced progression to type 2 diabetes by roughly 58%. Smaller losses still confer benefit but were not the trial's target.

  84. Question 84Nutrition, physical activity, and weight management

    Saturated fat intake for adults with diabetes is generally limited to approximately what proportion of total daily calories?

    1. Less than 7% of total calories Correct answer.
    2. Approximately 20% of total calories
    3. Approximately 25% of total calories
    4. Approximately 30% of total calories

    Explanation

    Nutrition guidance for diabetes limits saturated fat to less than 7% of total calories to reduce cardiovascular risk, with trans fat kept as low as possible. The remaining fat intake is best supplied by unsaturated sources such as nuts, seeds, and vegetable oils.

  85. Question 85Nutrition, physical activity, and weight management

    Which food provides approximately 15 g of carbohydrate in a single serving?

    1. One small apple Correct answer.
    2. One hard-boiled egg
    3. One cup of chopped lettuce
    4. One ounce of cheddar cheese

    Explanation

    Standard carbohydrate counting treats one small fresh fruit, one slice of bread, one-third cup of cooked rice, or 8 oz of milk as about 15 g of carbohydrate. Lettuce, cheese, and eggs are very low in carbohydrate and are not counted.

  86. Question 86Nutrition, physical activity, and weight management

    To judge how a meal affected blood glucose, when should a person check glucose?

    1. Three to four hours after finishing the meal
    2. Immediately before the meal is eaten
    3. On waking, before any food or drink
    4. 1 to 2 hours after the first bite Correct answer.

    Explanation

    Postprandial glucose is assessed 1 to 2 hours after the first bite, which captures the peak response to the meal and reflects the match between carbohydrate intake, medication, and endogenous insulin release. Checking at other times answers different clinical questions.

  87. Question 87Nutrition, physical activity, and weight management

    Recommended dietary fiber intake is best expressed as which of the following?

    1. 10 g per 1000 kcal consumed
    2. 5 g per 1000 kcal consumed
    3. 14 g per 1000 kcal consumed Correct answer.
    4. 20 g per 1000 kcal consumed

    Explanation

    The Adequate Intake for fiber is 14 g per 1000 kcal, which translates to roughly 25 g per day for women and 38 g per day for men. This intake supports glycemic and lipid control as well as bowel health.

  88. Question 88Nutrition, physical activity, and weight management

    How often should adults with diabetes include resistance training in their routine?

    1. Every day, with no rest days allowed
    2. At least five sessions each week
    3. At least 2 sessions per week Correct answer.
    4. About once every two weeks

    Explanation

    Resistance training is recommended at least 2 times per week on nonconsecutive days, targeting major muscle groups. It improves insulin sensitivity, muscular strength, and body composition, and it complements aerobic activity.

  89. Question 89Nutrition, physical activity, and weight management

    A client uses an insulin-to-carbohydrate ratio of 1 unit per 15 g of carbohydrate. A meal contains 60 g of carbohydrate. How many units of rapid-acting insulin are needed for the meal?

    1. 6 units
    2. 2 units
    3. 4 units Correct answer.
    4. 8 units

    Explanation

    Divide the meal carbohydrate grams by the ratio denominator: 60 divided by 15 equals 4 units. The same ratio is applied to any meal size as long as the pre-meal glucose is at target.

  90. Question 90Nutrition, physical activity, and weight management

    For an adult with diabetes and stage 3 chronic kidney disease who is not on dialysis, the recommended daily protein intake is approximately which of the following?

    1. 0.4 g/kg per day
    2. 0.8 g/kg per day Correct answer.
    3. 1.5 g/kg per day
    4. 2.0 g/kg per day

    Explanation

    Nondialysis chronic kidney disease calls for about 0.8 g/kg per day of protein to limit hyperfiltration while preserving nutritional status. Intakes at this level should be adequate in energy and monitored for malnutrition.

  91. Question 91Nutrition, physical activity, and weight management

    A client who takes insulin plans a moderate-intensity walk and has a pre-exercise glucose of 90 mg/dL. What is the most appropriate action?

    1. Eat 15 to 30 g of carbohydrate before starting Correct answer.
    2. Take an extra dose of rapid-acting insulin first
    3. Postpone exercise until glucose is above 250 mg/dL
    4. Begin the workout immediately with no changes

    Explanation

    When pre-exercise glucose is under about 100 mg/dL in a person using insulin, adding 15 to 30 g of carbohydrate before activity reduces the risk of exercise-induced hypoglycemia. Glucose should also be checked during and after activity.

  92. Question 92Nutrition, physical activity, and weight management

    A client who uses insulin reports drinking several beers in the evening without eating. The greatest immediate concern is which of the following?

    1. Hyperglycemia developing within the first hour
    2. Immediate development of ketoacidosis
    3. Delayed hypoglycemia several hours later Correct answer.
    4. A rise in blood pressure during the night

    Explanation

    Alcohol blunts hepatic gluconeogenesis, so hypoglycemia can appear many hours after drinking, especially overnight and when alcohol replaces food. Clients should eat carbohydrate with alcohol and check glucose before bed.

  93. Question 93Nutrition, physical activity, and weight management

    When calculating an insulin dose for a packaged food, which value on the Nutrition Facts label is most important?

    1. Total fat content in grams
    2. Sugar content listed on the label
    3. Cholesterol content in milligrams
    4. Total carbohydrate in grams Correct answer.

    Explanation

    Bolus insulin is matched to total carbohydrate, which includes starches, sugars, and sugar alcohols listed under total carbohydrate. The sugar line alone undercounts starchy foods, and fat or cholesterol does not drive mealtime dosing.

  94. Question 94Nutrition, physical activity, and weight management

    Which statement best describes the glycemic index?

    1. It describes how much insulin is needed to cover one serving of food
    2. It ranks carbohydrate foods by their 2-hour blood glucose effect Correct answer.
    3. It ranks foods according to their calorie content per 100-gram serving
    4. It measures the total amount of carbohydrate in one serving of food

    Explanation

    The glycemic index compares equal carbohydrate portions of foods by the blood glucose response they produce over about 2 hours relative to a reference food. It is a quality measure of carbohydrate, not a measure of quantity, calories, or insulin dose.

  95. Question 95Nutrition, physical activity, and weight management

    Which daily energy deficit is generally recommended for gradual, sustainable weight loss?

    1. 100 to 200 kcal per day
    2. 250 to 300 kcal per day
    3. 1500 to 2000 kcal per day
    4. 500 to 750 kcal per day Correct answer.

    Explanation

    A deficit of roughly 500 to 750 kcal per day produces about 0.5 to 0.75 kg of loss per week and is better tolerated than severe restriction. Very large deficits risk lean mass loss, micronutrient gaps, and poor adherence.

  96. Question 96Nutrition, physical activity, and weight management

    What daily sodium limit is recommended for most adults with diabetes?

    1. Less than 2300 mg per day Correct answer.
    2. Less than 1800 mg per day
    3. Less than 1500 mg per day
    4. Less than 4000 mg per day

    Explanation

    Sodium intake is generally limited to less than 2300 mg per day for adults with diabetes, with further reduction considered for those with hypertension. Processed and restaurant foods are the main contributors.

  97. Question 97Nutrition, physical activity, and weight management

    Which activity is specifically recommended for older adults with diabetes to reduce fall risk?

    1. Balance training 2 to 3 times per week Correct answer.
    2. Bed rest on days with mild fatigue
    3. High-impact jumping exercises several times daily
    4. Daily stretching of the upper body only

    Explanation

    Older adults with diabetes benefit from flexibility and balance training 2 to 3 times per week, which improves stability and lowers fall risk. Balance work is added to, not substituted for, aerobic and resistance activity.

  98. Question 98Nutrition, physical activity, and weight management

    A client with type 1 diabetes completes vigorous exercise in the evening. What should the educator emphasize to reduce overnight hypoglycemia?

    1. Skip the scheduled evening insulin dose entirely
    2. Increase the bedtime insulin dose to prevent highs
    3. Perform exercise only when the stomach is empty
    4. Check bedtime glucose and eat a snack if it is low Correct answer.

    Explanation

    Evening exercise can cause hypoglycemia during the night because insulin sensitivity stays elevated for hours. Checking glucose at bedtime and adding carbohydrate when the value is low or trending down reduces this risk.

  99. Question 99Nutrition, physical activity, and weight management

    Which meal pattern is usually recommended for a client with diabetes and gastroparesis?

    1. Several small meals low in fat and fiber Correct answer.
    2. A high-fat liquid diet taken throughout the day
    3. One large meal eaten at bedtime each night
    4. Three large meals that are very high in fiber

    Explanation

    Delayed gastric emptying is managed with smaller, more frequent meals that are low in fat and fiber, since both nutrients slow gastric emptying. Glucose should be monitored after meals because absorption timing becomes unpredictable.

  100. Question 100Nutrition, physical activity, and weight management

    Using the diabetes plate method on a 9-inch plate, which food should fill the largest section?

    1. Non-starchy vegetables such as broccoli or green beans Correct answer.
    2. Fruit such as a whole orange or a cup of grapes
    3. Lean protein such as grilled chicken breast
    4. Whole grains such as brown rice or whole-wheat bread

    Explanation

    The plate method fills about half the plate with non-starchy vegetables, one quarter with lean protein, and one quarter with carbohydrate-containing foods. This layout lowers the glycemic load of the meal while preserving portion awareness.

  101. Question 101Nutrition, physical activity, and weight management

    A client presents 3 weeks after Roux-en-Y gastric bypass with confusion, ataxia, and nystagmus. Which nutrient deficiency is most likely?

    1. Calcium (calcium citrate)
    2. Vitamin C (ascorbic acid)
    3. Iron (ferrous sulfate)
    4. Thiamine (vitamin B1) Correct answer.

    Explanation

    Persistent vomiting and reduced intake after bariatric surgery can precipitate thiamine deficiency, producing Wernicke encephalopathy with confusion, ataxia, and ocular signs. It is a medical emergency requiring prompt parenteral thiamine.

  102. Question 102Nutrition, physical activity, and weight management

    Which exercise guidance is appropriate for a client with active proliferative retinopathy?

    1. Engage in repeated jumping and high-impact jarring activity
    2. Perform maximal heavy lifting to improve glycemic control
    3. Avoid heavy resistance training and Valsalva maneuvers Correct answer.
    4. Use head-down inverted positions during core exercises

    Explanation

    Activities that sharply raise intraocular pressure or blood pressure, such as maximal resistance work and breath-holding, increase the risk of vitreous hemorrhage or retinal detachment in proliferative retinopathy. Moderate aerobic activity is generally preferred.

  103. Question 103Nutrition, physical activity, and weight management

    A food serving contains 30 g of total carbohydrate and 8 g of dietary fiber. Using the common fiber adjustment for insulin dosing, how many grams of carbohydrate should be used?

    1. 26 g Correct answer.
    2. 30 g
    3. 22 g
    4. 38 g

    Explanation

    When a serving contains more than 5 g of fiber, subtracting half of the fiber grams from total carbohydrate is a commonly used adjustment: 8 divided by 2 equals 4, and 30 minus 4 equals 26 g. The full fiber amount is not subtracted because some fiber is fermented and partially absorbed.

  104. Question 104Nutrition, physical activity, and weight management

    Why may a client need a reduced insulin dose for many hours after prolonged vigorous exercise?

    1. Exercise permanently increases hepatic glucose production
    2. Exercise blocks carbohydrate absorption from the small intestine
    3. Insulin sensitivity stays elevated, raising hypoglycemia risk Correct answer.
    4. Exercise reduces insulin sensitivity for many hours afterward

    Explanation

    Muscle glucose uptake remains enhanced after exercise, so insulin sensitivity can stay elevated for up to 24 to 48 hours. This underlies the recommendation to reduce insulin and monitor glucose well beyond the activity itself.

  105. Question 105Nutrition, physical activity, and weight management

    A client with type 1 diabetes has a glucose of 280 mg/dL and moderate blood ketones before a planned workout. What should the educator advise?

    1. Drink water and exercise as planned
    2. Postpone exercise and treat the ketones first Correct answer.
    3. Take extra rapid-acting insulin and then exercise
    4. Proceed with light exercise only

    Explanation

    Hyperglycemia with moderate or large ketones signals insulin deficiency, and exercise would drive free fatty acid production and worsen ketosis. Insulin and fluids should be given and exercise withheld until ketones clear and glucose is controlled.

  106. Question 106Nutrition, physical activity, and weight management

    A conscious adult with diabetes has a blood glucose of 58 mg/dL, can swallow safely, and has no intravenous access. How much fast-acting carbohydrate should be given as the initial treatment?

    1. 5 g of carbohydrate
    2. 50 g of carbohydrate
    3. 100 g of carbohydrate
    4. 15 g of carbohydrate Correct answer.

    Explanation

    Hypoglycemia in a conscious adult who can swallow is treated with the 15-15 rule: 15 g of fast-acting carbohydrate, a glucose recheck in about 15 minutes, and a repeat dose if glucose remains below 70 mg/dL. Larger initial amounts are not needed and increase the chance of rebound hyperglycemia.

  107. Question 107Nutrition, physical activity, and weight management

    What is the minimum recommended volume of moderate-intensity aerobic activity per week for most adults with diabetes?

    1. 420 minutes
    2. 300 minutes
    3. 150 minutes Correct answer.
    4. 75 minutes

    Explanation

    Adults with diabetes are advised to accumulate at least 150 minutes of moderate-intensity aerobic activity each week, spread over at least three days with no more than two consecutive days off. Greater volumes may be needed for weight-loss goals, but they are not the minimum threshold.

  108. Question 108Nutrition, physical activity, and weight management

    Which dietary component has the greatest effect on the postprandial glucose rise after a meal?

    1. Total carbohydrate, including sugars and starches Correct answer.
    2. Sugar alcohols, which are absorbed and metabolized entirely as glucose
    3. Dietary protein, which is converted to glucose in the liver
    4. Dietary fat, which slows gastric emptying and blunts the rise

    Explanation

    Carbohydrate is digested to monosaccharides and is the macronutrient that most directly raises postprandial glucose. Fat and protein influence glucose indirectly and to a much smaller degree, and sugar alcohols are only partially absorbed and metabolized.

  109. Question 109Nutrition, physical activity, and weight management

    Which nutrient should be monitored in a client who has taken metformin for many years?

    1. Iron, because metformin blocks intestinal iron transporters
    2. Folate, because metformin increases folate requirements
    3. Vitamin B12, which is malabsorbed with long-term use Correct answer.
    4. Calcium, because metformin reduces renal calcium reabsorption

    Explanation

    Metformin can impair vitamin B12 absorption, and long-term use has been associated with deficiency that may present as anemia or peripheral neuropathy. Periodic monitoring is suggested for people on prolonged therapy, particularly those with risk factors.

  110. Question 110Nutrition, physical activity, and weight management

    A client who takes glipizide plans a 45-minute brisk walk before breakfast without eating first. What is the most appropriate precaution?

    1. Exercise only late in the evening after the largest meal
    2. Skip the glipizide dose on exercise days without consulting the prescriber
    3. Check glucose before and after exercise and carry fast-acting carbohydrate Correct answer.
    4. Avoid all aerobic activity while taking a sulfonylurea

    Explanation

    Sulfonylureas stimulate insulin secretion regardless of food intake, so exercise that improves insulin sensitivity can precipitate hypoglycemia. Checking glucose around the session and carrying fast-acting carbohydrate is the safe approach, while medication changes require prescriber involvement.

  111. Question 111Nutrition, physical activity, and weight management

    What is the first-line nutrition approach for a client newly diagnosed with gestational diabetes?

    1. Medical nutrition therapy with carbohydrate spread over the day Correct answer.
    2. Starting insulin immediately and allowing unrestricted carbohydrate intake
    3. A ketogenic diet providing fewer than 20 g of carbohydrate per day
    4. Eliminating all fruit and dairy products until delivery

    Explanation

    Medical nutrition therapy is first-line for gestational diabetes, typically distributing carbohydrate across three meals and two to three snacks to blunt postprandial peaks. Pharmacotherapy is added only when glucose targets are not met with nutrition and activity alone.

  112. Question 112Nutrition, physical activity, and weight management

    Which statement about eating patterns for adults with diabetes is best supported by current evidence?

    1. Eating patterns have little effect on glucose or lipid outcomes
    2. Very-low-carbohydrate diets are the only pattern shown to lower A1C
    3. A single macronutrient distribution ratio is recommended for all adults with diabetes
    4. Mediterranean, DASH, and plant-based patterns are all reasonable choices Correct answer.

    Explanation

    Several eating patterns, including Mediterranean, DASH, plant-based, and reduced-carbohydrate approaches, have evidence for improving glycemia and cardiovascular risk. The pattern is individualized to the client's preferences, culture, and metabolic goals rather than dictated by one fixed macronutrient ratio.

  113. Question 113Nutrition, physical activity, and weight management

    A client with type 2 diabetes has painful peripheral neuropathy in both feet. Which activity is most appropriate to recommend?

    1. High-impact aerobic dance classes
    2. Prolonged stair climbing for aerobic fitness
    3. Daily treadmill running at a moderate pace
    4. Swimming or stationary cycling Correct answer.

    Explanation

    Repetitive weight-bearing activity on feet with painful or insensate neuropathy increases the risk of ulceration and injury. Non-weight-bearing activities such as swimming or cycling provide cardiovascular benefit while protecting the feet, along with daily foot inspection.

  114. Question 114Nutrition, physical activity, and weight management

    Which breakfast choice provides the most soluble fiber for lowering LDL cholesterol?

    1. White rice with grilled chicken breast and butter
    2. Cooked oatmeal topped with sliced banana Correct answer.
    3. Two scrambled eggs with two slices of white toast
    4. A plain bagel with cream cheese and jelly

    Explanation

    Oats are rich in beta-glucan, a viscous soluble fiber that binds bile acids and lowers LDL cholesterol; barley and legumes are similar sources. Refined grains and eggs contribute little soluble fiber.

  115. Question 115Nutrition, physical activity, and weight management

    Which strategy is most strongly associated with successful long-term weight maintenance after intentional weight loss?

    1. Weighing food only during the first month of the program
    2. Avoiding all social situations that involve food
    3. Using meal-replacement products indefinitely
    4. Regular self-monitoring of weight and dietary intake Correct answer.

    Explanation

    Ongoing self-monitoring, including regular weighing and tracking intake, is consistently associated with better weight maintenance, along with continued physical activity. Short-term vigilance, social withdrawal, and indefinite reliance on meal replacements are not durable maintenance strategies.

  116. Question 116Nutrition, physical activity, and weight management

    Which statement about nonnutritive sweeteners is accurate?

    1. They raise blood glucose as much as an equal weight of sucrose does
    2. They may be used within established acceptable daily intake limits Correct answer.
    3. They must be avoided by everyone with diabetes
    4. They provide about 4 kcal per gram, like sucrose

    Explanation

    Nonnutritive sweeteners are intensely sweet and contribute little or no energy, and regulatory agencies set acceptable daily intake limits for each. Use within those limits is considered safe for people with diabetes and does not meaningfully raise glucose.

  117. Question 117Nutrition, physical activity, and weight management

    A client with type 2 diabetes asks whether sugar must be completely eliminated from the diet. Which response is most accurate?

    1. Sucrose can be eaten in moderation when counted in total carbohydrate Correct answer.
    2. Sugar must be strictly avoided, and sweets replaced with sugar-free products
    3. Sugar is allowed only when eaten without other carbohydrate at the same meal
    4. Sugary foods are acceptable for anyone as long as total fat intake stays low

    Explanation

    Sucrose does not need to be eliminated; when counted within the total carbohydrate budget it has a glycemic effect similar to other carbohydrate sources. Nutrient-dense choices are still encouraged so that the overall diet meets vitamin, mineral, and fiber needs.

  118. Question 118Nutrition, physical activity, and weight management

    A client with obesity begins a very-low-calorie diet of 800 kcal per day using fortified meal replacements. Which monitoring is most important during the first weeks?

    1. Annual hemoglobin A1c testing only
    2. Monthly thyroid-stimulating hormone testing throughout the first year
    3. Serum potassium, magnesium, and phosphorus during the first weeks Correct answer.
    4. A daily fasting lipid panel for the first month

    Explanation

    Very-low-calorie diets cause rapid shifts in fluid and electrolyte balance and carry a risk of refeeding syndrome, so potassium, magnesium, and phosphorus should be checked early, particularly in the first weeks. Thyroid, lipid, and A1c testing are not the priority during induction.

  119. Question 119Nutrition, physical activity, and weight management

    An older adult with type 2 diabetes and obesity wants to lose weight while preserving muscle mass. Which plan best supports that goal?

    1. One large protein meal in the evening without resistance training
    2. About 25 to 30 g of protein at each meal plus resistance training twice weekly Correct answer.
    3. Protein supplements only on days that include aerobic exercise
    4. Protein intake below 0.6 g per kilogram of body weight daily to maximize fat loss

    Explanation

    Distributing 25 to 30 g of high-quality protein across meals, combined with resistance training, helps older adults preserve lean mass during energy restriction. Very low protein intakes accelerate muscle loss and should be avoided in this population.

  120. Question 120Nutrition, physical activity, and weight management

    A client with type 2 diabetes who takes empagliflozin announces plans to start a very-low-carbohydrate ketogenic diet. Which risk should the educator highlight most strongly?

    1. Iron-deficiency anemia from reduced meat intake
    2. Euglycemic diabetic ketoacidosis Correct answer.
    3. Hypernatremia caused by reduced fluid intake
    4. Vitamin C deficiency from reduced fruit intake

    Explanation

    SGLT2 inhibitors promote ketone production, and a very-low-carbohydrate diet adds further ketogenic substrate, raising the risk of ketoacidosis that can occur with near-normal glucose values. Clients need education about symptom recognition and about holding the medication during acute illness or prolonged fasting.

  121. Question 121Diabetes self-management education, behavior change, and psychosocial care

    According to the American Diabetes Association, diabetes self-management education and support (DSMES) should be offered at which set of four critical times?

    1. At diagnosis, then at 3, 6, and 12 months after starting education
    2. At every scheduled visit, regardless of glycemic control or needs
    3. Only at diagnosis and whenever a new medication is started
    4. At diagnosis, annually, with complications, and at transitions Correct answer.

    Explanation

    DSMES is recommended at diagnosis, annually or when targets are not met, when complicating factors develop, and during transitions in care. This schedule keeps knowledge and skills current as the person's health and circumstances change. Fixed intervals or visit-based delivery do not match the four critical times.

  122. Question 122Diabetes self-management education, behavior change, and psychosocial care

    The Association of Diabetes Care & Education Specialists' AADE7 Self-Care Behaviors framework includes which set of behaviors?

    1. Healthy coping, eating, activity, medication, monitoring, problem solving, risk reduction Correct answer.
    2. Glucose monitoring, ketone testing, injection technique, hypoglycemia treatment, sick-day rules, travel, and driving
    3. Carb counting, insulin titration, foot care, eye exams, dental care, smoking cessation, and exercise
    4. Meal planning, stress management, sleep hygiene, vaccination, lipid control, blood pressure control, and weight loss

    Explanation

    The AADE7 framework organizes self-management into healthy coping, healthy eating, being active, taking medication, monitoring, problem solving, and reducing risks. The other lists mix specific clinical tasks, targets, or situation-specific skills rather than the framework's behavior categories.

  123. Question 123Diabetes self-management education, behavior change, and psychosocial care

    A diabetes care and education specialist asks a patient to explain in their own words how to treat a low blood glucose reading. This technique is called:

    1. Behavioral chaining
    2. Teach-back Correct answer.
    3. Cognitive restructuring
    4. Motivational interviewing

    Explanation

    Teach-back is a communication method in which the learner restates information in their own words so the educator can confirm comprehension and correct gaps. It is not a counseling approach for ambivalence, a cognitive therapy technique, or a functional analysis of behavior chains.

  124. Question 124Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "I want to walk more." Which statement best converts this into a SMART goal?

    1. I will join a local fitness gym and exercise on a regular basis.
    2. I will try to be more physically active whenever I have some free time.
    3. I will walk 10 minutes after dinner on Mon, Wed, and Fri this week. Correct answer.
    4. I will aim to walk 10,000 steps every single day starting next month.

    Explanation

    A SMART goal is specific, measurable, achievable, relevant, and time-bound. The walking statement specifies the activity, duration, days, and a near-term timeframe, which makes follow-up and self-monitoring possible. The other statements are vague or lack a realistic short-term timeframe.

  125. Question 125Diabetes self-management education, behavior change, and psychosocial care

    The PHQ-9 is used in diabetes care primarily to:

    1. Evaluate health literacy and numeracy skills
    2. Measure diabetes-specific distress related to self-management
    3. Assess fear of hypoglycemia in people using insulin
    4. Screen for symptoms of depression over the past two weeks Correct answer.

    Explanation

    The PHQ-9 is a nine-item depression severity measure based on symptom criteria over the past two weeks. Diabetes distress and fear of hypoglycemia have separate instruments, and health literacy is assessed with other tools.

  126. Question 126Diabetes self-management education, behavior change, and psychosocial care

    A patient has been checking fasting glucose daily for the past three weeks and has started walking after lunch. In the transtheoretical model, this patient is best described as being in the:

    1. Maintenance stage
    2. Contemplation stage
    3. Action stage Correct answer.
    4. Preparation stage

    Explanation

    The action stage is when a person has begun the target behavior within the past six months. Preparation involves intention plus small steps, contemplation involves ambivalence, and maintenance involves sustained behavior beyond six months.

  127. Question 127Diabetes self-management education, behavior change, and psychosocial care

    Which strategy best supports a patient with limited health literacy during diabetes education?

    1. Provide a detailed printed handout with clinical terminology and ask the patient to read it at home.
    2. Recommend an online portal as the primary source of instruction.
    3. Use plain language, limit to 3 key points, and confirm understanding with teach-back. Correct answer.
    4. Speak quickly to cover all key points in a single session.

    Explanation

    Plain language, limiting the message to a few key points, and teach-back reduce cognitive load and confirm understanding. Detailed jargon-heavy handouts, rushed sessions, and portal-only instruction can widen disparities for people with limited literacy.

  128. Question 128Diabetes self-management education, behavior change, and psychosocial care

    Which statement best describes the role of social support in diabetes self-management?

    1. It is only helpful for children who have type 1 diabetes.
    2. It can buffer stress and support adherence and quality of life. Correct answer.
    3. It guarantees that the patient will adhere to the medication regimen.
    4. It can replace the need for clinical education and routine follow-up visits.

    Explanation

    Social support from family, peers, and community can buffer diabetes distress and support adherence and quality of life, but it does not replace clinical care or guarantee outcomes. Support needs vary across age groups and individuals.

  129. Question 129Diabetes self-management education, behavior change, and psychosocial care

    Patient: "I know I should check my blood sugar, but I get so frustrated when the numbers are high." Which response best demonstrates reflective listening in motivational interviewing?

    1. Checking sounds discouraging when results are not what you hoped for. Correct answer.
    2. Have you considered using a continuous glucose monitor to help with this?
    3. You really need to check more often so that your numbers will come down.
    4. High numbers are dangerous, so you should check your glucose anyway.

    Explanation

    A reflection captures and returns the patient's meaning and feeling, which supports exploration without judgment. Giving advice, asking a solutions-focused question, and warning are not reflective listening.

  130. Question 130Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "I know I need to start checking my feet, but I'm not sure I can make it a habit." Which approach best fits the contemplation stage?

    1. Avoid discussing foot care until the patient brings it up.
    2. Explore pros and cons of foot checks and build confidence. Correct answer.
    3. Assume the patient is ready and set a 30-day contract.
    4. Provide a detailed daily foot-care schedule to follow immediately.

    Explanation

    Contemplation is marked by ambivalence and intention without consistent action, so decisional balance and confidence-building fit this stage. Action-oriented plans fit preparation or action, and avoiding the topic is not appropriate.

  131. Question 131Diabetes self-management education, behavior change, and psychosocial care

    A patient believes that checking blood glucose at work will cause coworkers to question their competence. In the health belief model, this belief is best classified as a:

    1. Perceived barrier Correct answer.
    2. Perceived susceptibility
    3. Perceived severity
    4. Cue to action

    Explanation

    Perceived barriers are the tangible and psychological costs of a behavior, such as embarrassment or inconvenience. Susceptibility and severity concern the health threat, while cues to action are triggers that prompt behavior.

  132. Question 132Diabetes self-management education, behavior change, and psychosocial care

    Which strategy is most likely to strengthen self-efficacy for insulin injection in a newly diagnosed patient?

    1. Being told that injections are easy for most people
    2. Reading a brochure about injection technique
    3. Watching a video of a nurse giving an injection
    4. Giving a supervised injection with feedback Correct answer.

    Explanation

    Mastery experiences, successful performance with coaching and feedback, are the strongest source of self-efficacy. Vicarious learning, written information, and verbal persuasion are weaker sources.

  133. Question 133Diabetes self-management education, behavior change, and psychosocial care

    Which finding most suggests diabetes distress rather than major depression?

    1. Persistent loss of interest in nearly all activities for most of the day
    2. Two weeks of insomnia, guilt, and slowed psychomotor activity
    3. Worry about glucose checks and meals, with normal mood elsewhere Correct answer.
    4. A PHQ-9 score of 18 accompanied by active suicidal ideation

    Explanation

    Diabetes distress is specific to diabetes management and may not affect all life domains, whereas major depression is pervasive and can include anhedonia, suicidal ideation, and neurovegetative symptoms. A high PHQ-9 with suicidality requires urgent mental health assessment.

  134. Question 134Diabetes self-management education, behavior change, and psychosocial care

    Which approach best reflects shared decision making when choosing a glucose monitoring method?

    1. Options are explained, patient priorities elicited, and a plan agreed. Correct answer.
    2. The clinician selects the device that has the best accuracy data available.
    3. The patient is given a list of devices and told to make the decision alone.
    4. The educator postpones the decision until the A1C is above target.

    Explanation

    Shared decision making combines evidence-based options with patient values and preferences in a collaborative conversation. Clinician-only or patient-only decisions, and unnecessary delay, do not meet the model.

  135. Question 135Diabetes self-management education, behavior change, and psychosocial care

    Which practice best demonstrates cultural humility in diabetes education?

    1. Applying the same meal plan template to all patients from a given ethnic group.
    2. Assuming a patient's family will not support self-management.
    3. Using a translator only when the patient requests one.
    4. Asking about food practices and adapting recommendations to preferences. Correct answer.

    Explanation

    Cultural humility involves curiosity, self-reflection, and adapting care to the patient's own practices and preferences rather than stereotyping. Templates based on group identity, assumptions, and delayed interpreter use are not culturally humble.

  136. Question 136Diabetes self-management education, behavior change, and psychosocial care

    Which outcome is most supported by peer support or community health worker programs in diabetes care?

    1. Replacing medication management by the clinical team.
    2. Eliminating the need for any diabetes self-management education.
    3. Offering practical and emotional support to improve engagement. Correct answer.
    4. Providing legal advice for insurance disputes.

    Explanation

    Peer supporters and community health workers provide practical help, emotional support, and linkage to care, which can improve engagement and self-management. They do not replace clinical management or DSMES.

  137. Question 137Diabetes self-management education, behavior change, and psychosocial care

    Which intervention is most consistent with cognitive behavioral therapy for diabetes distress?

    1. Recommending long-term psychotherapy for everyone with diabetes
    2. Testing unhelpful thoughts about high glucose readings Correct answer.
    3. Ignoring negative thoughts and focusing only on A1C
    4. Providing a strict meal plan without discussion

    Explanation

    CBT targets unhelpful cognitive appraisals and behaviors through identification, challenge, and behavioral experiments. Ignoring thoughts, imposing rigid plans, and blanket referral are not CBT.

  138. Question 138Diabetes self-management education, behavior change, and psychosocial care

    A patient who stopped walking after a vacation wants to restart. Which response best supports problem solving and relapse prevention?

    1. Identify what got in the way and plan a specific restart step. Correct answer.
    2. Tell the patient that lapses mean the plan failed.
    3. Advise waiting until motivation returns.
    4. Recommend a much more intense exercise program to start immediately.

    Explanation

    Relapse prevention normalizes lapses, analyzes triggers, and builds a concrete coping plan for re-engagement. Labeling failure, escalating intensity abruptly, and waiting for motivation undermine self-efficacy.

  139. Question 139Diabetes self-management education, behavior change, and psychosocial care

    Which statement is an example of an implementation intention?

    1. I want to start eating much healthier foods sometime this year.
    2. If it is 7 a.m., I will check my fasting glucose. Correct answer.
    3. I will try much harder to remember to take my medications.
    4. I believe that I can manage my diabetes well on my own.

    Explanation

    Implementation intentions specify an if-then plan linking a cue to a behavior, which automates action. General desires, self-efficacy beliefs, and vague efforts are not if-then plans.

  140. Question 140Diabetes self-management education, behavior change, and psychosocial care

    A patient with limited numeracy needs to interpret a sliding-scale insulin order. Which approach is best?

    1. Use a color-coded chart with practice and teach-back. Correct answer.
    2. Explain the scale once in clinical terms.
    3. Provide the written scale and ask the patient to read it at home.
    4. Use a calculator without checking understanding.

    Explanation

    Lowering numeracy demands with visual aids, practice, and teach-back supports accurate insulin dosing. Written-only instruction, jargon, and unaided calculator use may increase error risk.

  141. Question 141Diabetes self-management education, behavior change, and psychosocial care

    A 19-year-old with type 1 diabetes has an A1C of 12% despite reporting consistent insulin use, and mentions stopping insulin to lose weight. Which concern is most likely?

    1. Insulin resistance related to puberty and growth
    2. Factitious hypoglycemia from unreported injections
    3. Somogyi effect from nighttime hypoglycemia
    4. Insulin omission for weight control (diabulimia) Correct answer.

    Explanation

    Intentional insulin omission to lose weight is a dangerous eating-disorder behavior associated with high A1C and ketoacidosis risk. Puberty can raise insulin resistance but does not explain stopping insulin for weight loss, and Somogyi describes rebound hyperglycemia after nocturnal hypoglycemia.

  142. Question 142Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "No matter what I do, my diabetes stays out of control." Which concept best describes this statement?

    1. Health literacy deficit
    2. Learned helplessness Correct answer.
    3. Decisional conflict
    4. High self-efficacy

    Explanation

    Learned helplessness reflects the belief that outcomes are uncontrollable, which can suppress effort. Self-efficacy is confidence in one's ability, health literacy is skill in understanding health information, and decisional conflict is uncertainty about choices.

  143. Question 143Diabetes self-management education, behavior change, and psychosocial care

    Which statement about the Diabetes Distress Scale (DDS) is most accurate?

    1. It diagnoses major depressive disorder.
    2. It measures diabetes-specific distress to guide discussion. Correct answer.
    3. It replaces the PHQ-9 for every patient in diabetes care.
    4. It is only valid for adolescents who have type 1 diabetes.

    Explanation

    The DDS measures diabetes-specific emotional distress across domains such as regimen, emotion, and interpersonal burden. It does not diagnose depression and is not limited to adolescents.

  144. Question 144Diabetes self-management education, behavior change, and psychosocial care

    Which experience best illustrates diabetes stigma in a clinical setting?

    1. Being asked to bring a detailed glucose log to an appointment
    2. Receiving a reminder about a scheduled A1C test
    3. Being offered a choice of insulin delivery devices
    4. A clinician implying that a high A1C reflects laziness Correct answer.

    Explanation

    Stigma involves blame, judgment, or stereotyping related to a health condition; implying laziness blames the patient and can reduce engagement. Reminders, log requests, and device choices are routine care.

  145. Question 145Diabetes self-management education, behavior change, and psychosocial care

    A patient with type 1 diabetes keeps glucose above 200 mg/dL to avoid low blood sugar and has stopped exercising. Which concern best explains this pattern?

    1. Depression with anhedonia
    2. Health literacy limitation
    3. Diabetes distress focused on meal planning
    4. Fear of hypoglycemia driving avoidance Correct answer.

    Explanation

    Fear of hypoglycemia can lead to avoidance of exercise and intentional maintenance of hyperglycemia. Diabetes distress, depression, and health literacy may co-occur but do not specifically explain fear-driven avoidance.

  146. Question 146Diabetes self-management education, behavior change, and psychosocial care

    The ADCES7 self-care behaviors include healthy eating, being active, monitoring, taking medication, reducing risks, healthy coping, and which additional behavior?

    1. Carbohydrate counting
    2. Insulin injection technique
    3. Problem solving Correct answer.
    4. Portion-size weighing

    Explanation

    The seven self-care behaviors are healthy eating, being active, monitoring, taking medication, problem solving, reducing risks, and healthy coping. Carbohydrate counting, injection technique, and portion sizing are specific skills that fall under healthy eating or taking medication rather than being one of the seven categories themselves.

  147. Question 147Diabetes self-management education, behavior change, and psychosocial care

    According to national standards, at which times should diabetes self-management education and support be offered?

    1. Every five years regardless of control
    2. Annually and at care transitions Correct answer.
    3. Only at the time of diagnosis
    4. Only after complications have developed

    Explanation

    DSMES is recommended at four critical times: at diagnosis, annually or when targets are not being met, when complicating factors develop, and during transitions in care. Limiting education to diagnosis, to the appearance of complications, or to a fixed multi-year interval misses these opportunities.

  148. Question 148Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "I'm not thinking about changing anything about my diabetes care in the next six months." Which stage of change does this reflect?

    1. Contemplation, since she has been considering her options
    2. Maintenance, since her habits have been stable for years
    3. Precontemplation Correct answer.
    4. Preparation, since she has set a start date

    Explanation

    Precontemplation is defined by no intention to change within the next six months. Contemplation involves intending to change within six months, preparation involves planning to act soon, and maintenance involves sustaining a change already made.

  149. Question 149Diabetes self-management education, behavior change, and psychosocial care

    When writing a behavior goal with a patient, which element satisfies the "T" in SMART criteria?

    1. It specifies a time frame for completion Correct answer.
    2. It focuses on the A1C result
    3. It can be measured in some way
    4. It is approved by the care team in advance

    Explanation

    SMART stands for specific, measurable, achievable, relevant, and time-bound, so the "T" refers to a defined time frame. Measurability belongs to the "M" element, and relevance is judged against what matters to the patient rather than against clinician approval or a single lab value.

  150. Question 150Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "Insulin shots would wreck my routine. I don't see why I'd ever start them." Which response is most consistent with motivational interviewing?

    1. Let me explain why your A1C means insulin is necessary now.
    2. You really need to reconsider, because insulin prevents complications.
    3. Most people feel that way at first and then they get used to it.
    4. Starting insulin feels like it would upend your routine. Correct answer.

    Explanation

    Motivational interviewing responds to sustain talk with reflective listening that conveys understanding without arguing. Reflecting the patient's concern keeps the conversation open, whereas correcting, reassuring, or lecturing tends to increase resistance.

  151. Question 151Diabetes self-management education, behavior change, and psychosocial care

    An educator has just explained how to rotate insulin injection sites. Which action best confirms the patient can actually perform the skill?

    1. Give the patient a printed handout and review it together
    2. Ask the patient to demonstrate site rotation on a body diagram Correct answer.
    3. Ask the patient, "Do you understand the steps?"
    4. Ask the patient to sign that teaching was completed

    Explanation

    Having the patient demonstrate the skill provides direct evidence of understanding and correct technique, which is the core of teach-back and return demonstration. A signature, a yes-or-no question, or a handout documents exposure but does not confirm learning.

  152. Question 152Diabetes self-management education, behavior change, and psychosocial care

    A patient says, "My father lost a leg to diabetes, so I know it could happen to me too." Which Health Belief Model construct does this statement reflect?

    1. Perceived barriers to care
    2. Cues to action from family
    3. Self-efficacy for self-care
    4. Perceived susceptibility Correct answer.

    Explanation

    Perceived susceptibility is a person's belief about the likelihood of developing a condition or complication. The statement expresses personal vulnerability to amputation rather than confidence in performing a behavior, a trigger to act, or an obstacle to care.

  153. Question 153Diabetes self-management education, behavior change, and psychosocial care

    A patient scores 3 on the PHQ-2 during routine diabetes screening. What is the most appropriate next step?

    1. Repeat the PHQ-2 at the next annual visit
    2. Diagnose major depression and start medication
    3. Begin diabetes distress counseling immediately
    4. Administer the full PHQ-9 to assess severity Correct answer.

    Explanation

    The PHQ-2 is a brief screen; a positive result prompts administration of the full PHQ-9 to gauge severity and guide next steps. Screening tools do not establish a diagnosis or justify starting medication on their own, and deferring follow-up leaves a positive screen unaddressed.

  154. Question 154Diabetes self-management education, behavior change, and psychosocial care

    A 14-year-old with type 1 diabetes argues with her parent every day about glucose checks, and her A1C is rising. Which approach should the educator take first?

    1. Advise the parent to stop discussing diabetes with the teen altogether
    2. Negotiate shared responsibilities and reduce blame around checks Correct answer.
    3. Recommend the parent take over all diabetes tasks
    4. Refer the family for suspected medical neglect

    Explanation

    In adolescents, family conflict and blame around diabetes tasks predict poorer control, so redistributing tasks and reducing criticism supports both autonomy and adherence. Fully taking over or abandoning discussion removes needed support, and rising A1C from conflict is not evidence of neglect.

  155. Question 155Diabetes self-management education, behavior change, and psychosocial care

    A patient with type 2 diabetes mentions in passing that she skips insulin some months. Which initial response is most appropriate?

    1. Simplify the regimen without asking about finances
    2. Review the importance of taking insulin as prescribed
    3. Note the missed doses in the chart and continue the plan
    4. Explore cost barriers and connect her to lower-cost options Correct answer.

    Explanation

    Cost-related nonadherence is common and requires direct, nonjudgmental exploration followed by practical solutions such as lower-cost formulations, assistance programs, or regimen adjustment. Restating the importance of adherence or silently documenting the gap does not address the underlying barrier.

  156. Question 156Diabetes self-management education, behavior change, and psychosocial care

    A patient sets a goal of walking 60 minutes daily but rates her confidence at 3 out of 10. What is the best next step?

    1. Praise the ambition and encourage her to push through
    2. Ask her to commit to the 60-minute goal for two weeks before deciding
    3. Help her scale the goal down to something she is confident she can do Correct answer.
    4. Suggest she find a workout partner to stay accountable

    Explanation

    Goals should be set at a level the person believes is achievable; low confidence predicts failure and erodes self-efficacy. Shrinking the goal to a realistic step builds mastery, after which the goal can be increased.

  157. Question 157Diabetes self-management education, behavior change, and psychosocial care

    Which patient statement is an example of change talk?

    1. My spouse keeps nagging me about my diet
    2. My doctor says I have to lose weight
    3. I could probably start checking my glucose before breakfast Correct answer.
    4. I've tried everything and nothing ever works

    Explanation

    Change talk expresses the patient's own desire, ability, reasons, or need for change, as in stating a possible action she could take. Statements about external pressure, past failure, or a clinician's instructions reflect sustain talk or outside motivation rather than the patient's own argument for change.

  158. Question 158Diabetes self-management education, behavior change, and psychosocial care

    Which statement by an educator best reflects the empowerment-based approach to diabetes education?

    1. If you don't follow this plan, you will end up on dialysis.
    2. What matters most to you, and how does diabetes fit in? Correct answer.
    3. You need to be more disciplined about your eating.
    4. I have set your goals for you, so just stick to the plan.

    Explanation

    Empowerment-based education starts with the patient's own values and priorities and supports collaborative goal setting and autonomy. Fear-based warnings, pre-set goals, and blame-based advice reflect a compliance-oriented, directive model instead.

  159. Question 159Diabetes self-management education, behavior change, and psychosocial care

    A patient with type 2 diabetes who takes a sulfonylurea and basal insulin plans to fast during Ramadan. What is the most appropriate educator action?

    1. Arrange a pre-fast risk assessment and medication plan with the prescriber Correct answer.
    2. Tell her to skip all diabetes medications on fasting days
    3. Reassure her that fasting is safe with any medication regimen
    4. Advise her to fast only on weekends to limit the risk

    Explanation

    Fasting during Ramadan carries hypoglycemia risk with sulfonylureas and insulin, so pre-fast risk stratification and an individualized medication adjustment plan made with the prescriber are recommended. Blanket reassurance, unplanned medication omission, or improvised partial fasting does not address the risk.

  160. Question 160Diabetes self-management education, behavior change, and psychosocial care

    A patient with type 2 diabetes and newly diagnosed moderate depression says she has no energy for diabetes tasks. Which approach is best supported by current evidence?

    1. Focus on diabetes tasks and address mood only if A1C stays high
    2. Offer depression treatment alongside ongoing diabetes self-management support Correct answer.
    3. Defer diabetes education until her depression remits
    4. Advise her to stop glucose monitoring until she feels better

    Explanation

    Depression and diabetes are closely linked, and integrated or collaborative care that treats mood while continuing self-management support improves both depressive symptoms and glycemic outcomes. Deferring diabetes care or stopping monitoring lets both conditions worsen, and waiting for A1C to rise delays indicated treatment.

  161. Question 161Monitoring, technology, complications, and special populations

    Hemoglobin A1C reflects average blood glucose over which period of time?

    1. The preceding 4 to 6 weeks
    2. The preceding 2 to 3 months Correct answer.
    3. The preceding 6 to 12 months
    4. The preceding 7 to 10 days

    Explanation

    A1C is formed when glucose binds irreversibly to hemoglobin over the lifespan of the red blood cell, roughly 120 days, so it reflects average glycemia over about 2 to 3 months and is weighted toward the most recent 4 weeks.

  162. Question 162Monitoring, technology, complications, and special populations

    An adult with diabetes has a glucose of 58 mg/dL and is awake and able to swallow. What is the recommended first action?

    1. Give 15 g of fast-acting carbohydrate and recheck in 15 minutes Correct answer.
    2. Inject 1 mg of glucagon subcutaneously
    3. Give 30 g of complex carbohydrate combined with a protein source
    4. Administer 15 units of rapid-acting insulin

    Explanation

    Conscious hypoglycemia is treated with the rule of 15: 15 g of fast-acting carbohydrate, wait 15 minutes, then recheck glucose and repeat if it remains below 70 mg/dL.

  163. Question 163Monitoring, technology, complications, and special populations

    Which instruction is most appropriate for a patient with diabetes and loss of protective foot sensation?

    1. Inspect the feet daily, including the soles, using a mirror Correct answer.
    2. Walk barefoot at home to improve circulation
    3. Trim corns and calluses with a sharp blade
    4. Soak the feet in warm water for 20 minutes each evening

    Explanation

    Daily inspection of the entire foot, including the plantar surface with a mirror or helper, allows early detection of trauma, blisters, and redness before ulceration occurs. Patients with sensory loss should never walk barefoot or perform self-surgery on the feet.

  164. Question 164Monitoring, technology, complications, and special populations

    What preprandial capillary glucose goal is recommended for most nonpregnant adults with diabetes?

    1. 100 to 140 mg/dL
    2. 80 to 130 mg/dL Correct answer.
    3. 60 to 90 mg/dL
    4. 70 to 110 mg/dL

    Explanation

    The commonly recommended preprandial target for most nonpregnant adults is 80 to 130 mg/dL, with a peak postprandial value below 180 mg/dL. Targets are individualized for age, comorbidities, and hypoglycemia risk.

  165. Question 165Monitoring, technology, complications, and special populations

    Which screening test is recommended for identifying loss of protective sensation in the diabetic foot?

    1. Transcutaneous oxygen sensor
    2. 128-Hz tuning fork
    3. 10-g monofilament Correct answer.
    4. Ankle-brachial index cuff

    Explanation

    The 10-g monofilament is the standard bedside measure of loss of protective sensation because it approximates the pressure threshold above which injury occurs without warning. Vibration testing with a tuning fork complements but does not replace monofilament testing.

  166. Question 166Monitoring, technology, complications, and special populations

    Which A1C goal is most appropriate for an older adult with multiple chronic illnesses, functional impairment, and limited life expectancy?

    1. Less than 7.5%
    2. Less than 7.0%
    3. Less than 6.5%
    4. Less than 8.0% Correct answer.

    Explanation

    For older adults with complex or intermediate health status, a less stringent goal such as less than 8.0% reduces hypoglycemia and treatment burden while still avoiding symptomatic hyperglycemia. Tighter goals are reserved for healthy older adults with intact function.

  167. Question 167Monitoring, technology, complications, and special populations

    What A1C target is recommended for most children and adolescents with type 1 diabetes?

    1. Less than 6.5%
    2. Less than 6.0%
    3. Less than 7.0% Correct answer.
    4. Less than 8.0%

    Explanation

    A target below 7.0% is recommended for most children and adolescents with type 1 diabetes, with individualization for hypoglycemia risk, age, and family circumstances. Achieving this goal requires comprehensive technology and self-management support.

  168. Question 168Monitoring, technology, complications, and special populations

    What blood pressure goal is recommended for most adults with diabetes?

    1. Less than 120/70 mmHg
    2. Less than 130/80 mmHg Correct answer.
    3. Less than 150/90 mmHg
    4. Less than 140/90 mmHg

    Explanation

    A blood pressure goal of less than 130/80 mmHg is recommended for most adults with diabetes to reduce cardiovascular and microvascular events. Therapy typically begins with lifestyle change plus an ACE inhibitor, ARB, thiazide, or calcium channel blocker.

  169. Question 169Monitoring, technology, complications, and special populations

    For a blood glucose meter meeting current ISO 15197 standards, within what percentage must readings fall for at least 95% of results when glucose is 100 mg/dL or higher?

    1. Plus or minus 10%
    2. Plus or minus 5%
    3. Plus or minus 20%
    4. Plus or minus 15% Correct answer.

    Explanation

    ISO 15197:2013 requires that at least 95% of meter results fall within 15 mg/dL of the reference at glucose below 100 mg/dL and within 15% at glucose of 100 mg/dL or higher. Meters exceeding this error can lead to unsafe insulin dosing.

  170. Question 170Monitoring, technology, complications, and special populations

    For most adults with diabetes, what proportion of time in range (70 to 180 mg/dL) should be targeted on continuous glucose monitoring?

    1. At least 60%
    2. At least 50%
    3. At least 80%
    4. At least 70% Correct answer.

    Explanation

    The consensus goal is time in range above 70% of readings, with less than 4% of time below 70 mg/dL and less than 1% below 54 mg/dL. Time in range complements A1C because it captures both hypoglycemia and glycemic variability.

  171. Question 171Monitoring, technology, complications, and special populations

    A patient with diabetic ketoacidosis has a glucose of 480 mg/dL, blood pressure of 88/54 mmHg, and a heart rate of 122 beats per minute. What is the initial management priority?

    1. Oral rehydration with water and electrolyte solution
    2. Rapid intravenous infusion of 0.9% sodium chloride Correct answer.
    3. Intravenous administration of sodium bicarbonate
    4. Intravenous bolus of 10 units of regular insulin

    Explanation

    Volume resuscitation with isotonic saline comes first in DKA because these patients are profoundly volume depleted and insulin given before fluid replacement can worsen hypotension. Insulin infusion begins after fluids are started and potassium has been assessed.

  172. Question 172Monitoring, technology, complications, and special populations

    During an acute illness with vomiting, which instruction is most appropriate for a patient using basal-bolus insulin?

    1. Continue basal insulin and monitor glucose and ketones often Correct answer.
    2. Take only the mealtime insulin and skip the basal dose
    3. Stop all insulin until able to eat and drink normally
    4. Halve the basal insulin on the first sick day

    Explanation

    Basal insulin must be continued during illness because it suppresses ketogenesis even when intake is poor. Glucose should be checked every few hours and ketones monitored, with supplemental rapid-acting insulin according to a sick-day plan.

  173. Question 173Monitoring, technology, complications, and special populations

    Which pair of tests is recommended for annual screening of diabetic kidney disease?

    1. Serum potassium and blood urea nitrogen
    2. Urine albumin-to-creatinine ratio and eGFR Correct answer.
    3. Urine culture and bladder scan
    4. Renal ultrasound with creatinine clearance measurement

    Explanation

    Chronic kidney disease screening in diabetes uses a spot urine albumin-to-creatinine ratio plus estimated glomerular filtration rate, repeated annually. Either marker alone can miss disease because albuminuria and reduced filtration rate do not always develop together.

  174. Question 174Monitoring, technology, complications, and special populations

    When should a patient newly diagnosed with type 2 diabetes be referred for an initial dilated comprehensive eye examination?

    1. After 1 year of diabetes duration
    2. At the time of diagnosis Correct answer.
    3. After 5 years of diabetes duration
    4. Only when visual symptoms appear

    Explanation

    Type 2 diabetes may be present for years before diagnosis, so retinopathy can already exist; an initial dilated eye examination is therefore performed at diagnosis and repeated annually. In type 1 diabetes, the first examination is within 5 years of onset.

  175. Question 175Monitoring, technology, complications, and special populations

    Which finding best supports a diagnosis of diabetic gastroparesis?

    1. Bloody diarrhea with tenesmus and rectal urgency
    2. Postprandial hyperglycemia that responds to extra rapid-acting insulin
    3. Epigastric burning pain that is reliably relieved by antacids
    4. Early satiety and vomiting of food eaten hours earlier Correct answer.

    Explanation

    Gastroparesis is delayed gastric emptying without obstruction, producing early satiety, bloating, nausea, and vomiting of undigested food long after meals. Diagnosis is confirmed by a gastric emptying study after mechanical obstruction is excluded.

  176. Question 176Monitoring, technology, complications, and special populations

    Which A1C target is recommended during pregnancy when it can be achieved without hypoglycemia?

    1. Less than 7.0%
    2. Less than 8.0%
    3. Less than 6.0% Correct answer.
    4. Less than 5.5%

    Explanation

    An A1C below 6.0% is recommended in pregnancy if achievable without significant hypoglycemia, supported by targets of fasting below 95 mg/dL and 1- and 2-hour postprandial values below 140 and 120 mg/dL. Tight control lowers the risk of congenital anomalies and macrosomia.

  177. Question 177Monitoring, technology, complications, and special populations

    A patient with type 1 diabetes who is ill has a capillary blood beta-hydroxybutyrate level of 3.4 mmol/L. What is the most appropriate action?

    1. Take extra basal insulin and recheck ketones in 4 hours
    2. Go to the emergency department for evaluation Correct answer.
    3. Reduce carbohydrate intake and continue usual insulin
    4. Drink fluids and recheck ketones in 6 hours

    Explanation

    A blood beta-hydroxybutyrate level of 3.0 mmol/L or higher indicates high risk for diabetic ketoacidosis and warrants immediate contact with the care team or emergency evaluation. Earlier thresholds (0.6 to 1.5 mmol/L) prompt supplemental insulin and hydration at home.

  178. Question 178Monitoring, technology, complications, and special populations

    Which patient with diabetes meets current criteria for routine moderate-intensity statin therapy?

    1. A 45-year-old with type 2 diabetes and an LDL of 60 mg/dL
    2. A 30-year-old with type 1 diabetes and an LDL of 70 mg/dL
    3. A 55-year-old with diabetes and no ASCVD Correct answer.
    4. A 25-year-old with a history of gestational diabetes

    Explanation

    Adults aged 40 to 75 years with diabetes should receive at least moderate-intensity statin therapy regardless of baseline LDL cholesterol. Younger patients are treated when additional risk factors or established atherosclerotic disease are present.

  179. Question 179Monitoring, technology, complications, and special populations

    A patient with diabetes who takes a nonselective beta-blocker is at increased risk for which effect?

    1. Masking of tremor and palpitations of hypoglycemia Correct answer.
    2. Increased hepatic glucose production during the night
    3. Falsely elevated A1C results
    4. Delayed absorption of oral glucose taken for a low

    Explanation

    Beta-blockers blunt the adrenergic warning symptoms of hypoglycemia such as tremor, palpitations, and anxiety, which can delay recognition and treatment. They may also modestly impair glycogenolysis, slowing recovery from a low.

  180. Question 180Monitoring, technology, complications, and special populations

    Which statement best describes hypoglycemia unawareness?

    1. Loss of the ability to taste sweet foods during hypoglycemia
    2. A marked fear of hypoglycemia leading to insulin avoidance
    3. Low glucose that occurs only during the overnight hours
    4. Absence of warning symptoms before glucose falls very low Correct answer.

    Explanation

    In hypoglycemia unawareness, the autonomic warning symptoms that normally prompt action are blunted or absent, often after repeated episodes of low glucose. Management includes relaxing glycemic targets, avoiding lows, and structured education.

  181. Question 181Monitoring, technology, complications, and special populations

    Which condition is most likely to make A1C appear falsely low relative to the true average glucose?

    1. Prior splenectomy
    2. Hemolytic anemia Correct answer.
    3. Chronic kidney disease with low erythropoietin
    4. Iron deficiency anemia

    Explanation

    A1C depends on red cell survival; hemolytic anemia shortens it, so glycated hemoglobin is removed from circulation before it accumulates and the result underestimates average glucose. Conditions such as iron deficiency and B12 deficiency prolong or alter red cell turnover and typically raise A1C.

  182. Question 182Monitoring, technology, complications, and special populations

    A patient with type 1 diabetes who takes an SGLT2 inhibitor presents with nausea, vomiting, and abdominal pain. Glucose is 210 mg/dL and blood ketones are 4.2 mmol/L. Which condition should the educator suspect?

    1. Lactic acidosis related to metformin use
    2. Hyperosmolar hyperglycemic state
    3. Euglycemic diabetic ketoacidosis Correct answer.
    4. Hypoglycemia unawareness

    Explanation

    SGLT2 inhibitors promote glucosuria and can precipitate ketoacidosis with glucose levels below the usual DKA threshold, so called euglycemic DKA. Ketones must be checked whenever nausea, vomiting, or abdominal pain occur in a patient taking these agents.

  183. Question 183Monitoring, technology, complications, and special populations

    A patient using continuous glucose monitoring reports shakiness and sweating while the sensor reads 110 mg/dL; a fingerstick reads 62 mg/dL. What is the best explanation?

    1. Interstitial glucose lags blood glucose during rapid change Correct answer.
    2. The blood glucose meter is inaccurate and should be replaced
    3. The patient is anxious in a way that mimics hypoglycemia
    4. The sensor is failing and needs replacement

    Explanation

    Continuous monitors measure glucose in interstitial fluid, which trails blood glucose by several minutes when glucose is changing quickly, so a falling blood glucose can be lower than the sensor value. Symptomatic patients should always confirm with a fingerstick and treat the measured value.

  184. Question 184Monitoring, technology, complications, and special populations

    A patient has a fasting glucose of 210 mg/dL. Overnight glucose values show 58 mg/dL at 2 AM and 72 mg/dL at 3 AM. What is the most likely explanation for the elevated fasting value?

    1. Insufficient basal insulin overnight
    2. Rebound hyperglycemia after a nocturnal low Correct answer.
    3. Delayed absorption of the evening meal
    4. The dawn phenomenon with a morning cortisol surge

    Explanation

    Documented nocturnal hypoglycemia followed by morning hyperglycemia describes the Somogyi effect, in which counterregulatory hormone release drives rebound hyperglycemia. The corrective action is to reduce, not increase, the evening insulin dose.

  185. Question 185Monitoring, technology, complications, and special populations

    Which patient with diabetes is an appropriate candidate for low-dose aspirin therapy?

    1. A 38-year-old with type 2 diabetes and no added risk factors
    2. A 62-year-old with diabetes and prior myocardial infarction Correct answer.
    3. A 55-year-old with diabetes and well-controlled blood pressure
    4. A 45-year-old with type 1 diabetes and no vascular disease

    Explanation

    Aspirin at 75 to 162 mg daily is recommended for secondary prevention in patients with diabetes and established atherosclerotic cardiovascular disease. Primary prevention is considered only after shared decision-making in patients at increased cardiovascular risk.

  186. Question 186Monitoring, technology, complications, and special populations

    On a continuous glucose monitoring report, which metric estimates the laboratory A1C a person would be expected to have?

    1. Mean amplitude of glycemic excursions
    2. Coefficient of variation
    3. Glucose management indicator Correct answer.
    4. Time above range

    Explanation

    The glucose management indicator is calculated from mean sensor glucose and expresses it on the same scale as A1C, so it predicts the expected laboratory A1C. It is useful when sensor data cover enough days, but it is not a substitute for a measured A1C when the two diverge.

  187. Question 187Monitoring, technology, complications, and special populations

    Which instrument is used during the comprehensive foot examination to detect loss of protective sensation?

    1. Reflex hammer
    2. Tuning fork
    3. 10-g monofilament Correct answer.
    4. Handheld Doppler

    Explanation

    The 10-g monofilament applies a standardized force and identifies patients who cannot feel that pressure, which defines loss of protective sensation and predicts ulcer risk. Vibration and pulse testing provide different information and do not replace it.

  188. Question 188Monitoring, technology, complications, and special populations

    A conscious adult with diabetes has a capillary glucose of 54 mg/dL and is able to swallow safely. What is the most appropriate initial treatment?

    1. One tablespoon of table sugar
    2. A peanut butter sandwich
    3. 15 g of fast-acting carbohydrate Correct answer.
    4. A dose of glucagon injection

    Explanation

    Conscious hypoglycemia is treated with about 15 g of rapid-acting carbohydrate, followed by a recheck in 15 minutes and repetition if the glucose remains low. Glucagon is reserved for patients who cannot take oral carbohydrate safely.

  189. Question 189Monitoring, technology, complications, and special populations

    Unless a woman has known pre-existing diabetes, at what point in pregnancy is screening for gestational diabetes usually performed?

    1. At 24 to 28 weeks of gestation Correct answer.
    2. Only if glycosuria develops
    3. At the first prenatal visit for all women
    4. At 12 to 16 weeks of gestation

    Explanation

    Routine screening for gestational diabetes is performed at 24 to 28 weeks, when insulin resistance from placental hormones becomes prominent. Earlier testing is reserved for women with risk factors or suspected undiagnosed pre-existing diabetes.

  190. Question 190Monitoring, technology, complications, and special populations

    An insulin pump user has a glucose of 380 mg/dL, a blood beta-hydroxybutyrate of 1.2 mmol/L, and no symptoms of illness; the pump shows no alarm. What should be done first?

    1. Give extra fluid and recheck the sensor in 2 hours
    2. Increase the temporary basal rate and recheck in 4 hours
    3. Inject a correction dose and change the infusion set Correct answer.
    4. Change the pump battery and resume the same site

    Explanation

    Unexplained hyperglycemia with ketones in a pump user most often reflects interrupted subcutaneous insulin delivery, so a correction dose should be given by injection while the set and reservoir are replaced. Basal rate changes through a possibly occluded catheter cannot be relied on to deliver insulin.

  191. Question 191Monitoring, technology, complications, and special populations

    A patient with type 2 diabetes reports burning pain in both feet that is worse at night and interferes with sleep. Which oral medication is recommended as first-line therapy for this pain?

    1. Tramadol
    2. Colchicine
    3. Naproxen
    4. Duloxetine Correct answer.

    Explanation

    Duloxetine, pregabalin, gabapentin, and tricyclic agents are recommended first-line options for painful diabetic peripheral neuropathy. Nonsteroidal anti-inflammatory drugs and opioids are not preferred because of limited benefit and safety concerns.

  192. Question 192Monitoring, technology, complications, and special populations

    A 58-year-old with type 2 diabetes has an eGFR of 26 mL/min/1.73 m2 and a urine albumin-to-creatinine ratio of 620 mg/g. What is the most appropriate next step?

    1. Refer to a nephrologist Correct answer.
    2. Continue current therapy and recheck in 6 months
    3. Repeat testing in 1 year
    4. Restrict protein intake to 0.3 g/kg/day

    Explanation

    Referral to nephrology is indicated when eGFR falls below 30 mL/min/1.73 m2 or when albuminuria is markedly elevated, so that progression can be addressed and kidney replacement therapy planned. Extremely low protein intake is not advised because it risks malnutrition.

  193. Question 193Monitoring, technology, complications, and special populations

    Which patient should be prescribed a glucagon product?

    1. A patient with type 2 diabetes taking metformin and empagliflozin who has never had low glucose
    2. A patient with type 1 diabetes and two recent severe hypoglycemia episodes Correct answer.
    3. A patient with prediabetes who is treated with metformin alone
    4. A patient with type 2 diabetes on semaglutide without insulin

    Explanation

    Glucagon should be prescribed for anyone at meaningful risk of severe hypoglycemia, which includes people with type 1 diabetes and those with a history of severe episodes on insulin or sulfonylureas. Agents that do not cause hypoglycemia do not warrant a glucagon prescription.

  194. Question 194Monitoring, technology, complications, and special populations

    A woman with type 1 diabetes and mild nonproliferative retinopathy is planning pregnancy. What monitoring is recommended?

    1. Eye examination once at the first prenatal visit
    2. No eye exams until 1 year after delivery
    3. Eye examination only if the patient reports blurred vision or floaters
    4. Dilated eye exams each trimester and for 1 year postpartum Correct answer.

    Explanation

    Pregnancy can accelerate retinopathy, so dilated examinations are recommended each trimester and for the first year postpartum. Exams triggered only by symptoms would miss clinically significant disease, which is often asymptomatic early.

  195. Question 195Monitoring, technology, complications, and special populations

    A CGM report shows a mean glucose of 150 mg/dL and a standard deviation of 68 mg/dL. Which statement about glycemic variability is correct?

    1. The coefficient of variation is 68%, which is acceptable
    2. The coefficient of variation is 22%, within goal
    3. The coefficient of variation is 45%, above the 36% goal Correct answer.
    4. The coefficient of variation cannot be determined from a single CGM report

    Explanation

    Coefficient of variation is the standard deviation divided by the mean, so 68 divided by 150 equals about 45%. A value above 36% indicates greater variability than recommended and warrants review of the glucose pattern.

  196. Question 196Monitoring, technology, complications, and special populations

    A patient with type 2 diabetes and peripheral neuropathy presents with a warm, red, swollen foot with intact skin and no reported injury. What is the most appropriate action?

    1. Apply a compression wrap and encourage walking
    2. Reassure the patient that this is a normal neuropathy finding
    3. Prescribe an oral antibiotic and allow weight bearing as tolerated
    4. Immobilize the foot and refer urgently for imaging Correct answer.

    Explanation

    A warm, swollen, erythematous foot in a patient with neuropathy suggests acute Charcot neuroarthropathy, which requires offloading and urgent imaging to prevent deformity. Antibiotics and continued weight bearing risk progression when infection is not the cause.

  197. Question 197Monitoring, technology, complications, and special populations

    A patient with type 2 diabetes controlled on metformin starts high-dose prednisone each morning and develops glucose readings of 240 to 300 mg/dL every afternoon and evening. Which adjustment is most appropriate?

    1. Increase the evening dose of metformin to cover the afternoon rise
    2. Add a morning dose of intermediate-acting insulin Correct answer.
    3. Add rapid-acting insulin at bedtime
    4. Add a sulfonylurea at bedtime

    Explanation

    Glucocorticoid-induced hyperglycemia predominantly affects the afternoon and evening, matching the pharmacodynamics of a morning intermediate-acting insulin such as NPH. Insulin is preferred because it can be titrated to the predictable steroid effect.

  198. Question 198Monitoring, technology, complications, and special populations

    An older adult with type 2 diabetes has a glucose of 1,080 mg/dL, serum osmolality of 352 mOsm/kg, pH 7.34, bicarbonate of 22 mEq/L, and trace urine ketones. Which condition is present, and what is the first priority?

    1. Hyperosmolar hyperglycemic state; start aggressive IV fluids Correct answer.
    2. Alcoholic ketoacidosis; give dextrose and thiamine
    3. Lactic acidosis; give sodium bicarbonate
    4. Diabetic ketoacidosis; start an insulin bolus and infusion

    Explanation

    Marked hyperglycemia with very high osmolality, minimal ketosis, and near-normal pH defines hyperosmolar hyperglycemic state, in which profound dehydration is the main threat. Volume resuscitation with isotonic fluid precedes insulin, which is started after fluids are underway.

  199. Question 199Monitoring, technology, complications, and special populations

    A 72-year-old with type 2 diabetes and an eGFR of 20 mL/min/1.73 m2 has had three hypoglycemia episodes at glucose 50 mg/dL while taking glimepiride and basal insulin. Which medication change is most appropriate?

    1. Add metformin
    2. Add a thiazolidinedione
    3. Increase the basal insulin dose
    4. Discontinue glimepiride Correct answer.

    Explanation

    Sulfonylureas and their active metabolites accumulate in advanced kidney disease, prolonging hypoglycemia, so glimepiride should be stopped and the insulin dose reviewed. Metformin is contraindicated at this eGFR, and adding another glucose-lowering agent would not address the cause.

  200. Question 200Monitoring, technology, complications, and special populations

    A patient with long-standing type 1 diabetes has orthostatic hypotension attributed to autonomic neuropathy. Which initial measure is most appropriate?

    1. Fludrocortisone as first-line therapy
    2. Bed rest with fluid restriction
    3. Increased salt and fluid intake with compression stockings Correct answer.
    4. Atenolol to reduce heart rate variability

    Explanation

    Nonpharmacologic measures come first for neurogenic orthostatic hypotension: expanding intravascular volume with salt and fluid and using compression garments. Pharmacologic agents such as fludrocortisone or midodrine are added when these measures are insufficient.

CDCES flashcards

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Type 1 diabetes mechanism
Autoimmune destruction of pancreatic beta cells causes absolute insulin deficiency, usually with positive islet autoantibodies such as GAD65, IA-2, ZnT8, or insulin; lifelong exogenous insulin is required.
Type 2 diabetes pathophysiology
Insulin resistance combined with progressive beta-cell failure produces relative insulin deficiency; type 2 diabetes accounts for about 90%–95% of diagnosed diabetes in U.S. adults and is strongly associated with obesity.
Diabetes diagnostic A1C threshold
An A1C of 6.5% or higher meets a diabetes diagnostic criterion; confirmation with a second abnormal test is generally required unless hyperglycemia is unequivocal.
Prediabetes A1C range
Prediabetes is defined by A1C 5.7%–6.4%, fasting plasma glucose 100–125 mg/dL, or 2-hour OGTT glucose 140–199 mg/dL.
DPP lifestyle reduction
In the Diabetes Prevention Program, intensive lifestyle intervention reduced progression from impaired glucose tolerance to type 2 diabetes by 58%, compared with 31% for metformin.
Gestational diabetes definition
Gestational diabetes is glucose intolerance first recognized during pregnancy; it increases future maternal type 2 diabetes risk and is usually screened for at 24–28 weeks.
MODY inheritance pattern
Maturity-onset diabetes of the young is monogenic and autosomal dominant, often diagnosed before age 25; common forms involve GCK or HNF1A and are not autoimmune.
A1C target most adults
The A1C goal is below 7% for most nonpregnant adults; less stringent goals such as below 8% are used for limited life expectancy, severe hypoglycemia risk, or advanced complications.
Preprandial glucose target
Preprandial capillary glucose target is 80–130 mg/dL, and peak postprandial glucose target is below 180 mg/dL measured 1–2 hours after the start of a meal.
Metformin eGFR contraindication
Metformin is contraindicated when estimated glomerular filtration rate is below 30 mL/min/1.73 m²; it is first-line therapy for type 2 diabetes unless contraindicated.
SGLT2 inhibitor key risks
SGLT2 inhibitors cause glycosuria and can cause genital mycotic infections, volume depletion, and euglycemic diabetic ketoacidosis; they reduce heart failure hospitalization and CKD progression.
GLP-1 RA contraindication
GLP-1 receptor agonists are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2; common effects include nausea, vomiting, and weight loss.
Rapid-acting insulin timing
Rapid-acting insulin analogs such as lispro, aspart, and glulisine begin in 5–15 minutes, peak near 1 hour, and last 3–5 hours.
Hypoglycemia high-risk drugs
Insulin and sulfonylureas carry the highest hypoglycemia risk; metformin, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists have low intrinsic hypoglycemia risk.
Carbohydrate choice grams
One carbohydrate choice equals 15 grams of carbohydrate; mealtime insulin dosing can use an individualized insulin-to-carbohydrate ratio.
Fiber recommendation diabetes
Adults with diabetes are advised to consume at least 14 grams of fiber per 1,000 kcal, commonly about 25–30 grams per day.
Weight loss glycemic threshold
Weight loss of 5%–7% of body weight improves glycemia and reduces progression to type 2 diabetes; loss of 10% or more can produce greater metabolic benefit.
Exercise weekly recommendation
Recommended physical activity is at least 150 minutes per week of moderate-intensity aerobic activity plus 2–3 sessions per week of resistance training.
Post-exercise hypoglycemia risk
Aerobic activity can lower blood glucose during and for up to 24 hours after exercise, increasing hypoglycemia risk in people using insulin or sulfonylureas.
Sedentary interruption frequency
Prolonged sedentary time should be interrupted every 30 minutes with light activity such as standing or walking.
DSMES critical times
DSMES is recommended at diagnosis, annually or when targets are not met, when complicating factors develop, and during transitions in care.
ADCES7 self-care behaviors
The ADCES7 behaviors are healthy coping, healthy eating, being active, taking medication, monitoring, reducing risks, and problem solving.
Diabetes distress prevalence
Diabetes distress affects roughly 20%–40% of adults with diabetes and is distinct from major depression, although the two conditions commonly co-occur.
Motivational interviewing OARS
Motivational interviewing is collaborative and autonomy-supportive; core skills include open questions, affirmations, reflections, and summaries, known as OARS.
Transtheoretical model stages
The stages are precontemplation, contemplation, preparation, action, maintenance, and possible relapse; progression is not necessarily linear.
Teach-back method
Teach-back confirms understanding by asking patients to explain information in their own words; it is a health-literacy strategy that reveals gaps.
CGM time in range targets
CGM targets are time in range 70–180 mg/dL above 70%, time below 70 mg/dL under 4%, time below 54 mg/dL under 1%, and time above 250 mg/dL under 5%.
Glucose management indicator formula
Glucose management indicator in percent equals 3.31 plus 0.02392 multiplied by mean glucose in mg/dL; it estimates A1C from CGM data.
Albuminuria definition
Albuminuria is a urine albumin-to-creatinine ratio of 30 mg/g or higher; adults with diabetes should be screened annually with UACR and eGFR.
Retinopathy screening start
Retinopathy screening begins within 5 years of type 1 diagnosis and at type 2 diagnosis, then annually or every 1–2 years if no retinopathy is present.
Hypoglycemia 15-15 rule
Treat hypoglycemia with 15 grams of fast-acting carbohydrate, recheck glucose in 15 minutes, and repeat until glucose is above 70 mg/dL; use glucagon for severe cases.
DKA diagnostic criteria
DKA criteria include glucose above 250 mg/dL, arterial pH below 7.3, bicarbonate below 18 mEq/L, anion gap, and ketonemia or ketonuria; HHS has minimal ketones.

CDCES study guide

Diabetes Pathophysiology, Epidemiology, and Prevention

Pathophysiology

Type 1 diabetes is caused by autoimmune destruction of pancreatic beta cells, producing absolute insulin deficiency; islet autoantibodies (GAD65, IA-2, ZnT8) may appear years before symptoms, and a substantial minority present in diabetic ketoacidosis. Type 2 diabetes reflects insulin resistance plus progressive beta-cell failure, worsened by an incretin defect, excess glucagon, and increased hepatic glucose output. Linking mechanism to medication class is a favorite exam move: metformin suppresses hepatic glucose production, GLP-1 receptor agonists restore the incretin effect, SGLT2 inhibitors cause glycosuria.

Epidemiology

Prevalence rises with age, obesity, and certain populations ( Indigenous, Hispanic, African American, Asian American, Pacific Islander), and many people have prediabetes or undiagnosed disease for years. Gestational diabetes is typically screened at 24-28 weeks with a 75-g 2-hour OGTT (one-step) or a two-step 50-g screen followed by a 100-g 3-hour test.

Diagnosis and prevention

Diagnostic thresholds: A1c ≥6.5%, fasting plasma glucose ≥126 mg/dL (8-hour fast), 2-hour OGTT ≥200 mg/dL, or random glucose ≥200 mg/dL with classic symptoms. Prediabetes: A1c 5.7-6.4%, impaired fasting glucose 100-125 mg/dL, impaired glucose tolerance 140-199 mg/dL. The Diabetes Prevention Program showed intensive lifestyle (7% weight loss, 150 min/week activity) cut progression to type 2 diabetes by 58%, versus 31% with metformin.

Traps

A1c is unreliable in hemoglobinopathies, pregnancy, hemolysis, recent transfusion, and dialysis; use plasma glucose instead. Iron deficiency can falsely raise A1c. A single normal glucose does not exclude diabetes in a symptomatic patient, and screening requires confirmation with a second test unless the diagnosis is unequivocal.

Pharmacotherapy and Glycemic Targets

Glycemic targets

For many nonpregnant adults the A1c goal is <7%, with preprandial glucose 80-130 mg/dL and peak postprandial <180 mg/dL. Individualize: a less stringent goal (<8%) suits limited life expectancy, severe hypoglycemia risk, advanced complications, or frailty; a tighter goal (<6.5%) may fit newly diagnosed, long life expectancy, and low hypoglycemia risk, provided it is achieved without burden. A1c is an average, not a measure of variability or hypoglycemia.

Medication logic

Metformin remains first-line for type 2 diabetes when tolerated and not contraindicated. Do not initiate metformin at eGFR <45; discontinue at eGFR <30; hold around iodinated contrast when eGFR is 30-60 and recheck renal function in 48 hours. For patients with atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease, add an SGLT2 inhibitor and/or GLP-1 receptor agonist with proven benefit, independent of A1c or metformin use. Insulin is required for type 1 diabetes and for symptomatic or catabolic type 2 presentations (A1c >10%, glucose ≥300, ketosis). Sulfonylureas and insulin carry hypoglycemia risk; SGLT2 inhibitors carry genital mycotic infection, volume depletion, and euglycemic ketoacidosis risk.

Traps

Questions often test drug-disease mismatch, such as an SGLT2 inhibitor in recurrent genital infections, or a sulfonylurea in an older adult with erratic meals. Fixing one number with a drug that causes hypoglycemia is not a correct answer. Do not stop metformin for mild eGFR decline without checking the threshold.

Rule of thumb

Choose therapy in this order: comorbidity-driven indication first, hypoglycemia risk and renal function second, cost and adherence third, A1c-lowering potency last.

Nutrition, Physical Activity, and Weight Management

Nutrition

There is no single "diabetic diet." Medical nutrition therapy delivered by a registered dietitian lowers A1c by roughly 1% in type 2 diabetes and is built around individual preference, culture, and metabolic goals. Emphasize nonstarchy vegetables, whole fruits, legumes, whole grains, and adequate fiber (about 14 g per 1000 kcal), limit added sugars and refined grains, and keep sodium under 2300 mg/day. Carbohydrate counting or consistent carbohydrate intake supports glycemic control; the total amount of carbohydrate matters more than its source. Moderate alcohol is acceptable with hypoglycemia awareness. Weight loss of 5-15% improves glycemia, lipids, and blood pressure and can drive type 2 diabetes into remission.

Physical activity

Aim for at least 150 minutes per week of moderate-to-vigorous aerobic activity spread over at least 3 days, with no more than 2 consecutive days without activity, plus resistance training 2-3 times weekly and flexibility/balance work for older adults. Activity improves insulin sensitivity for hours and reduces A1c by about 0.3-0.7%.

Safety

For people on insulin or a secretagogue, check glucose before exercise; if it is below about 90-100 mg/dL, add 15-30 g carbohydrate first. Avoid vigorous activity when ketones are present. Teach the 15-15 rule for hypoglycemia: 15 g fast carbohydrate, recheck in 15 minutes, repeat as needed, then eat a meal or snack.

Traps

Questions may suggest a rigid "forbidden food" list, skipping meals to control glucose, or advising people to stop insulin before exercise. None are correct. Also distinguish carbohydrate grams from glycemic index; low glycemic index foods are an option, not a mandate.

DSMES, Behavior Change, and Psychosocial Care

DSMES framework

Diabetes self-management education and support is organized around the ADCES7 self-care behaviors: healthy coping, healthy eating, being active, taking medication, monitoring, reducing risks, and problem solving. Offer DSMES at four critical times: at diagnosis, annually or when not meeting targets, when complicating factors develop, and during transitions in care. Education is not a one-time event and is most effective when delivered by a team including a diabetes care and education specialist.

Behavior change

Motivational interviewing is the core technique: use open questions, affirmations, reflections, and summaries (OARS) to evoke the person's own reasons for change, and follow the four processes of engaging, focusing, evoking, and planning. Assess readiness using the stages of change (precontemplation through maintenance) and match your approach: giving a detailed plan to someone in precontemplation usually triggers resistance. Goals should be SMART and patient-chosen, not clinician-imposed. Confirm understanding with teach-back and adapt to health literacy and numeracy.

Psychosocial care

Screen routinely for diabetes distress, depression, anxiety, disordered eating, and social determinants such as food insecurity and cost. Diabetes distress (measured with the DDS or PAID) is separate from major depression (screened with the PHQ-9 or PHQ-2) and is far more common; distress responds to education, peer support, and problem solving, while depression may need referral and pharmacotherapy. Refer to a mental health professional when symptoms are severe or impair self-management.

Traps

Do not equate a high A1c with poor motivation; assess barriers such as cost, depression, or food insecurity first. Do not use a distress scale to diagnose depression, and do not lecture or use scare tactics; both increase resistance.

Monitoring, Technology, Complications, and Special Populations

Monitoring and technology

Check A1c at least twice yearly when at goal and quarterly when therapy changes or goals are unmet. SMBG frequency depends on regimen: multiple daily injections and insulin pumps need frequent testing, while non-insulin regimens may need little. CGM metrics complement A1c: time in range 70-180 mg/dL >70%, time below range <4% (with <1% below 54 mg/dL), time above range <25%, and glucose management indicator (GMI ≈ 3.31 + 0.02392 × mean glucose in mg/dL). Coefficient of variation <36% indicates stable control. Confirm CGM readings with fingerstick when symptoms do not match, and never use CGM for treatment decisions without confirming within the device's labeled requirements.

Complications screening

Annual dilated retinal exam; urine albumin-to-creatinine ratio and eGFR at least annually; comprehensive foot exam yearly with visual inspection every visit; lipid panel and blood pressure at each visit, targeting <130/80 mmHg. Address smoking, vaccines, and dental care.

Special populations

Pregnancy targets are tighter (A1c <6%, fasting <95, 1-hour <140, 2-hour <120 mg/dL) and many medications must change. Older adults need simplified regimens and relaxed targets to avoid hypoglycemia. Chronic kidney disease requires renal dose adjustment and SGLT2 inhibitor consideration. Hospitalized patients generally use scheduled basal-bolus insulin rather than sliding scale alone.

Traps

Do not use A1c as the sole marker in dialysis, anemia, or after transfusion, and do not confuse GMI with a lab A1c. Do not attribute foot ulcers to neuropathy alone without assessing perfusion and infection.

CDCES cheat sheet

Quick reference

Diabetes Pathophysiology, Epidemiology, and Prevention

  • Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, causing absolute insulin deficiency; islet autoantibodies include GAD65, IA-2, ZnT8, and insulin.

  • Type 2 diabetes involves insulin resistance plus progressive beta-cell dysfunction, producing relative insulin deficiency; it accounts for about 90%–95% of diagnosed diabetes in U.S. adults.

  • Diagnostic thresholds: A1C ≥6.5%, fasting plasma glucose ≥126 mg/dL, 2-hour plasma glucose ≥200 mg/dL during a 75-g OGTT, or random glucose ≥200 mg/dL with classic symptoms.

  • Prediabetes ranges: A1C 5.7%–6.4%, fasting plasma glucose 100–125 mg/dL, or 2-hour OGTT glucose 140–199 mg/dL.

  • The Diabetes Prevention Program found intensive lifestyle intervention reduced progression from impaired glucose tolerance to type 2 diabetes by 58%, versus 31% with metformin.

  • Gestational diabetes is glucose intolerance first recognized during pregnancy; it raises later maternal type 2 diabetes risk and is typically screened for at 24–28 weeks.

  • MODY is monogenic, autosomal dominant diabetes often diagnosed before age 25; common forms involve GCK or HNF1A and are not autoimmune.

  • LADA is slowly progressive autoimmune diabetes in adults; patients are initially non-insulin-requiring and often have islet autoantibodies.

  • Risk of microvascular complications rises with glycemic exposure, diabetes duration, hypertension, and dyslipidemia.

Quick reference

Clinical Management: Pharmacotherapy and Glycemic Targets

  • A1C goal is <7% for most nonpregnant adults; less stringent goals (e.g., <8%) suit limited life expectancy, severe hypoglycemia risk, or advanced complications.

  • Preprandial capillary glucose target is 80–130 mg/dL; peak postprandial glucose target is <180 mg/dL, measured 1–2 hours after the start of a meal.

  • Metformin is first-line pharmacotherapy for type 2 diabetes unless contraindicated; it is contraindicated at eGFR <30 mL/min/1.73 m².

  • SGLT2 inhibitors with proven benefit reduce heart failure hospitalization and CKD progression; GLP-1 receptor agonists with proven benefit reduce major adverse cardiovascular events.

  • Insulin and sulfonylureas carry the highest hypoglycemia risk; metformin, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists have low intrinsic hypoglycemia risk.

  • Rapid-acting insulin analogs (lispro, aspart, glulisine) begin in 5–15 minutes, peak near 1 hour, and last 3–5 hours; regular insulin begins in about 30 minutes.

  • GLP-1 receptor agonists are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2; common effects include nausea, vomiting, and weight loss.

  • SGLT2 inhibitors cause glycosuria and can cause genital mycotic infections, volume depletion, and euglycemic diabetic ketoacidosis.

  • A1C reflects roughly 3 months of mean glycemia but is unreliable with hemoglobin variants, anemia, recent transfusion, or advanced kidney disease.

Quick reference

Nutrition, Physical Activity, and Weight Management

  • Medical nutrition therapy can lower A1C by approximately 0.3%–1.0% in type 2 diabetes and is most effective when delivered by a registered dietitian nutritionist.

  • One carbohydrate choice equals 15 g of carbohydrate; mealtime insulin dosing can use an individualized insulin-to-carbohydrate ratio.

  • Adults with diabetes are advised to consume at least 14 g of fiber per 1,000 kcal, commonly about 25–30 g/day.

  • Weight loss of 5%–7% of body weight improves glycemia and reduces progression to type 2 diabetes; loss of ≥10% can produce greater metabolic benefit.

  • Recommended physical activity is at least 150 minutes/week of moderate-intensity aerobic activity plus 2–3 sessions/week of resistance training.

  • Aerobic activity can lower blood glucose during and for up to 24 hours after exercise, increasing hypoglycemia risk in people using insulin or sulfonylureas.

  • Prolonged sedentary time should be interrupted every 30 minutes with light activity such as standing or walking.

  • Very-low-calorie diets can induce type 2 diabetes remission in some adults within 12 months, but remission rates vary and require long-term follow-up.

  • Alcohol can inhibit hepatic gluconeogenesis and cause delayed hypoglycemia, especially in insulin-treated patients.

Quick reference

Diabetes Self-Management Education, Behavior Change, and Psychosocial Care

  • DSMES is recommended at four critical times: at diagnosis, annually or when targets are not met, when complicating factors develop, and during transitions in care.

  • DSMES can reduce A1C by up to 0.6%–1.0% and improves diabetes knowledge, self-care behaviors, and quality of life.

  • The ADCES7 Self-Care Behaviors are healthy coping, healthy eating, being active, taking medication, monitoring, reducing risks, and problem solving.

  • Diabetes distress affects roughly 20%–40% of adults with diabetes and is distinct from major depression, though the two commonly co-occur.

  • The PHQ-9 screens for depressive symptoms; the Diabetes Distress Scale (DDS) or PAID measures diabetes-specific emotional distress.

  • Motivational interviewing is collaborative and autonomy-supportive; core skills include open questions, affirmations, reflections, and summaries (OARS).

  • The transtheoretical model stages are precontemplation, contemplation, preparation, action, maintenance, and possible relapse.

  • Teach-back confirms understanding by asking patients to explain information in their own words; it is a health-literacy strategy.

  • Food insecurity, medication cost, housing instability, and transportation barriers are social determinants that directly affect diabetes self-management.

Quick reference

Monitoring, Technology, Complications, and Special Populations

  • A1C is checked at least every 3 months when not at goal and at least every 6 months when at goal.

  • CGM targets: time in range 70–180 mg/dL >70%, time below 70 mg/dL <4%, time below 54 mg/dL <1%, time above 180 mg/dL <25%, and time above 250 mg/dL <5%.

  • Glucose management indicator (GMI, %) = 3.31 + 0.02392 × mean glucose in mg/dL.

  • Albuminuria is defined as urine albumin-to-creatinine ratio ≥30 mg/g; adults with diabetes should be screened annually with UACR and eGFR.

  • Retinopathy screening begins within 5 years of type 1 diagnosis and at type 2 diagnosis, then annually or every 1–2 years if no retinopathy.

  • Annual comprehensive foot exam includes 10-g monofilament testing, vibration or pinprick sensation, pulses, and visual inspection for ulcers or deformity.

  • Hypoglycemia treatment: 15 g fast-acting carbohydrate, recheck glucose in 15 minutes, and repeat until glucose is >70 mg/dL; use glucagon for severe hypoglycemia.

  • DKA criteria include glucose >250 mg/dL, arterial pH <7.3, bicarbonate <18 mEq/L, anion gap, and ketonemia or ketonuria; HHS has glucose >600 mg/dL and osmolality >320 mOsm/kg with minimal ketones.

  • Pregnancy targets in diabetes: A1C <6% if achievable without hypoglycemia, fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, and 2-hour postprandial <120 mg/dL.

CDCES key terms

Prediabetes

Blood glucose higher than normal but below the diabetes thresholds: A1C 5.7–6.4%, fasting glucose 100–125 mg/dL, or a 2-hour oral glucose tolerance test of 140–199 mg/dL. It signals elevated risk and is a target for prevention.

Related: Diabetes Prevention Program (DPP), A1C
Insulin resistance

A state in which muscle, fat, and liver cells respond poorly to insulin, so the pancreas must release more insulin to move glucose into cells. It underlies type 2 diabetes and often accompanies obesity and inactivity.

Related: Beta-cell dysfunction, Metabolic syndrome
Beta-cell dysfunction

Loss or impairment of pancreatic beta cells' ability to make and release insulin in response to glucose. This progressive decline drives worsening hyperglycemia in both type 1 and type 2 diabetes.

Related: C-peptide, Islet autoantibodies
Islet autoantibodies

Immune proteins such as GAD65, IA-2, ZnT8, and insulin antibodies that attack pancreatic beta cells. Their presence confirms autoimmune type 1 diabetes and can predict progression in at-risk relatives.

Related: Beta-cell dysfunction, C-peptide
Gestational diabetes mellitus

Hyperglycemia first recognized during pregnancy, usually in the second or third trimester, caused partly by pregnancy hormones increasing insulin resistance. It raises risks for the pregnant person and the fetus and requires screening and treatment.

Related: Insulin resistance, Individualized glycemic target
Metabolic syndrome

A cluster of conditions - central obesity, high triglycerides, low HDL cholesterol, high blood pressure, and elevated fasting glucose - that together raise the risk of type 2 diabetes and cardiovascular disease.

Related: Insulin resistance, Prediabetes
Dawn phenomenon

An early-morning rise in blood glucose caused by overnight release of growth hormone, cortisol, and other counter-regulatory hormones that increase insulin resistance. It occurs without preceding nocturnal hypoglycemia.

Related: Basal-bolus insulin, Continuous glucose monitoring (CGM)
Diabetes Prevention Program (DPP)

A large U.S. randomized trial showing that intensive lifestyle change (7% weight loss plus 150 minutes per week of activity) cut progression from prediabetes to type 2 diabetes by 58%, outperforming metformin.

Related: Prediabetes, Weight loss of 5–10%
C-peptide

A fragment released when the pancreas converts proinsulin into insulin, so it reflects the body's own insulin production. It helps distinguish type 1 from type 2 diabetes and track beta-cell decline over time.

Related: Beta-cell dysfunction, Islet autoantibodies
A1C

A blood test that reflects average glucose over roughly the previous 2–3 months by measuring glycated hemoglobin. It is used both for diagnosis and for monitoring glycemic control, reported as a percentage.

Related: Individualized glycemic target, Time in range
Metformin

A biguanide that lowers liver glucose production and improves insulin sensitivity. It is usually the first medication for type 2 diabetes and does not cause hypoglycemia when used by itself.

Related: Insulin resistance, Individualized glycemic target
GLP-1 receptor agonist

An injectable or oral drug that mimics the gut hormone GLP-1, boosting glucose-dependent insulin release, slowing gastric emptying, reducing appetite, and promoting weight loss; several agents also lower cardiovascular risk.

Related: SGLT2 inhibitor, Weight loss of 5–10%
SGLT2 inhibitor

An oral drug that blocks sodium-glucose cotransporter 2 in the kidney, so glucose is excreted in urine. Benefits include lower weight and blood pressure plus heart and kidney protection in many patients.

Related: GLP-1 receptor agonist, Albumin-to-creatinine ratio (UACR)
Sulfonylurea

An oral drug that stimulates pancreatic beta cells to release insulin regardless of the glucose level. It lowers A1C effectively but carries meaningful risk of hypoglycemia and weight gain.

Related: Hypoglycemia levels, Beta-cell dysfunction
Basal-bolus insulin

An intensive regimen pairing long-acting background insulin with rapid-acting mealtime doses adjusted to carbohydrate intake and glucose readings, approximating normal pancreatic insulin release across the day.

Related: Carbohydrate counting, Dawn phenomenon
Hypoglycemia levels

Standard classification: Level 1 is glucose below 70 mg/dL; Level 2 is below 54 mg/dL; Level 3 is any severe event with altered mental or physical status requiring assistance, regardless of the glucose value.

Related: 15-15 rule, Individualized glycemic target
Individualized glycemic target

A personal A1C goal chosen with the patient based on age, diabetes duration, comorbidities, hypoglycemia risk, and preferences - often below 7% for many nonpregnant adults, but higher or lower when warranted.

Related: A1C, Shared decision-making
DPP-4 inhibitor

An oral drug that slows breakdown of the body's incretin hormones, modestly increasing glucose-dependent insulin release and lowering glucagon. It is weight-neutral with low hypoglycemia risk but limited A1C reduction.

Related: GLP-1 receptor agonist, Metformin
Medical nutrition therapy

Individualized nutrition assessment and counseling delivered by a registered dietitian nutritionist and tailored to the person's health status, culture, schedule, and goals. It is a core component of diabetes care and education.

Related: Carbohydrate counting, Diabetes self-management education and support (DSMES)
Carbohydrate counting

A meal-planning method in which the person tracks grams of carbohydrate eaten and uses an insulin-to-carbohydrate ratio, or keeps intake consistent, to match insulin doses and control post-meal glucose.

Related: Basal-bolus insulin, Glycemic index
Glycemic index

A ranking of carbohydrate-containing foods by how quickly they raise blood glucose compared with a reference food. Lower-index foods digest more slowly and produce a gentler rise in glucose.

Related: Carbohydrate counting, Medical nutrition therapy
15-15 rule

Treatment for mild hypoglycemia: eat or drink 15 grams of fast-acting carbohydrate, wait 15 minutes, recheck glucose, and repeat until glucose is above 70 mg/dL, then eat a snack or meal if needed.

Related: Hypoglycemia levels, Sulfonylurea
Physical activity recommendation

For most adults with diabetes: at least 150 minutes per week of moderate-to-vigorous aerobic activity spread over at least 3 days with no more than 2 consecutive days off, plus resistance training 2–3 times weekly.

Related: Weight loss of 5–10%, Insulin resistance
Weight loss of 5–10%

Losing 5–10% of body weight improves glycemia, blood lipids, and blood pressure; losing 10% or more, especially soon after diagnosis, can bring type 2 diabetes into remission for some people.

Related: Diabetes Prevention Program (DPP), Metabolic surgery
Metabolic surgery

Bariatric procedures such as sleeve gastrectomy or gastric bypass that change the digestive tract and reduce intake. They can produce substantial weight loss and improvement or remission of type 2 diabetes in eligible patients.

Related: Weight loss of 5–10%, Medical nutrition therapy
Diabetes self-management education and support (DSMES)

An ongoing, person-centered process that helps people with diabetes build the knowledge, skills, and confidence needed for daily self-care. It is delivered by qualified diabetes care and education specialists and coordinated with the care team.

Related: ADCES7 Self-Care Behaviors, Motivational interviewing
ADCES7 Self-Care Behaviors

Seven behaviors that frame diabetes education: healthy coping, healthy eating, being active, taking medication, monitoring, reducing risks, and problem solving. Educators use them to structure assessment and goal setting.

Related: Diabetes self-management education and support (DSMES), Shared decision-making
Motivational interviewing

A collaborative counseling style using open questions, affirmations, reflections, and summaries to draw out a person's own reasons for change, rather than advising, warning, or persuading them.

Related: Shared decision-making, Health literacy
Diabetes distress

Emotional burden from living with and managing diabetes - worry, frustration, and burnout about self-care. It is distinct from depression and, when unaddressed, is linked to poorer glycemic outcomes.

Related: Diabetes self-management education and support (DSMES), ADCES7 Self-Care Behaviors
Health literacy

The ability to obtain, understand, and use health information to make decisions. Low health literacy calls for plain language, teach-back, picture-based materials, and simpler medication regimens.

Related: Shared decision-making, Social determinants of health
Shared decision-making

A conversation in which clinician and patient exchange information about options, benefits, and risks, then agree on a plan that reflects the patient's values, priorities, and life circumstances.

Related: Individualized glycemic target, Motivational interviewing
Social determinants of health

Conditions of where people live, work, learn, and play - income, food security, housing, transportation, and social support - that shape diabetes risk and a person's ability to self-manage day to day.

Related: Health literacy, Diabetes distress
Continuous glucose monitoring (CGM)

A device with a sensor under the skin that measures interstitial glucose every few minutes and sends readings to a receiver or phone, displaying trends plus alerts for impending highs and lows.

Related: Time in range, Dawn phenomenon
Time in range

The percentage of time glucose stays within a target range, typically 70–180 mg/dL, on continuous glucose monitoring. It complements A1C by capturing daily variability and exposure to hypoglycemia.

Related: Continuous glucose monitoring (CGM), A1C
Albumin-to-creatinine ratio (UACR)

A urine test comparing albumin with creatinine to detect early kidney damage. Two of three samples at 30 mg/g or higher indicate albuminuria and prompt kidney-protective treatment such as an SGLT2 inhibitor.

Related: SGLT2 inhibitor, A1C
Diabetic ketoacidosis

A life-threatening complication of severe insulin deficiency in which the body burns fat and produces acidic ketones. It presents with hyperglycemia, dehydration, nausea, abdominal pain, and rapid deep breathing.

Related: Sick-day management, Continuous glucose monitoring (CGM)
Sick-day management

A plan for managing diabetes during illness: keep taking insulin, check glucose and ketones more often, stay hydrated, and use supplemental insulin as directed to prevent ketoacidosis and severe hyperglycemia.

Related: Diabetic ketoacidosis, Diabetes self-management education and support (DSMES)
Monofilament test

A screening test for loss of protective sensation in the feet: a 10-gram nylon filament is pressed against specified sites until it bends, and missed points suggest neuropathy and elevated ulcer risk.

Related: ADCES7 Self-Care Behaviors, A1C

CDCES study plan

8 weeks · About 7 hours per week

Week 1

Clinical management: pharmacotherapy and glycemic targets

  • Map every major antihyperglycemic class (metformin, sulfonylureas, meglitinides, TZDs, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, dual GIP/GLP-1 agonists, basal and prandial insulins) onto a one-page table listing mechanism, A1C-lowering potency, weight effect, hypoglycemia risk, contraindications, and monitoring labs

  • Rank the drug classes by cardiorenal outcome evidence and justify in writing which agents you would prioritize for a patient with established ASCVD, heart failure, or CKD

  • Sequence the guideline-based intensification steps from metformin monotherapy through dual, triple, and injectable therapy, noting the A1C thresholds that trigger each step

  • Rehearse insulin initiation math: calculate starting basal dose at 10 units/day or 0.1-0.2 units/kg, titration by 2 units every 3 days, and correction-factor and insulin-to-carbohydrate estimates

Your checkpoint

A hand-drawn or typed drug-class comparison table covering at least 10 agents, self-quizzed closed-book with 90% recall

Week 2

Clinical management: pharmacotherapy and glycemic targets & Diabetes pathophysiology, epidemiology, and prevention

  • List the diagnostic criteria for diabetes and prediabetes (A1C, fasting plasma glucose, 2-hour OGTT, random glucose with symptoms) and state which require confirmation on a repeat sample

  • Compare glycemic targets for nonpregnant adults, older adults with comorbidities, pregnancy, and hospitalized patients, and defend each target in a short written rationale

  • Explain the pathophysiology of type 1, type 2, and gestational diabetes in terms of beta-cell function, insulin resistance, and incretin defect, and connect each defect to the drug class that addresses it

  • Calculate and interpret A1C-to-estimated-average-glucose conversions and identify conditions that make A1C unreliable (hemoglobinopathies, anemia, CKD, pregnancy, recent transfusion)

Your checkpoint

A two-page target-and-diagnosis cheat sheet with 10 self-written clinical vignettes answered at 80% or better

Week 3

Monitoring, technology, complications, and special populations

  • Interpret CGM reports using time in range, time below range, time above range, glucose management indicator, and coefficient of variation, and write a three-sentence clinical interpretation for three sample tracings you construct yourself

  • Differentiate meter, CGM, and A1C data by what each measures and when each is appropriate, including CGM eligibility and personal versus professional use

  • Teach the hypoglycemia levels and treatment: 15-15 rule for level 1, glucagon and IV dextrose for level 3, and prevention strategies for nocturnal and exercise-related lows

  • Describe screening schedules for retinopathy, nephropathy (eGFR plus urine albumin-to-creatinine ratio), neuropathy, and foot exams, and state the interval for each

Your checkpoint

A one-page monitoring-and-screening calendar plus a written interpretation of three self-built CGM scenarios

Week 4

Monitoring, technology, complications, and special populations

  • Outline the acute complications of DKA and hyperosmolar hyperglycemic state with precipitating factors, key lab findings, and emergency management priorities

  • Summarize macrovascular and microvascular complication prevention, including blood pressure targets, statin therapy, smoking cessation, and foot-care teaching points

  • Adapt care for special populations: pregnancy and gestational diabetes, older adults with frailty, adolescents and transition-age youth, hospitalized and perioperative patients, and people with CKD or on dialysis

  • Write sick-day rules and travel and shift-work plans that a patient could follow independently

Your checkpoint

A four-case special-population worksheet (pregnancy, older adult, adolescent, CKD) with written management plans scored against a checklist you create

Week 5

Nutrition, physical activity, and weight management

  • Build a carbohydrate-counting teaching sequence that moves from label reading to portion estimation to insulin-to-carb ratio application

  • Compare meal-planning approaches (carbohydrate counting, plate method, Mediterranean-style eating, very-low-carbohydrate diets, plant-based patterns) and match each to patient characteristics

  • Translate the physical activity recommendations into a progressive plan for adults with type 2 diabetes, including aerobic, resistance, flexibility, and balance components with glucose-monitoring guidance around exercise

  • Apply weight-management evidence, including the diabetes prevention program's 7% weight-loss and 150-minute activity targets and the role of anti-obesity pharmacotherapy and metabolic surgery

  • Counsel on alcohol, fasting, and hypoglycemia risk during and after exercise using a written script

Your checkpoint

A seven-day sample meal plan with carbohydrate grams per meal plus a written activity progression plan for a hypothetical sedentary adult

Week 6

Diabetes self-management education, behavior change, and psychosocial care

  • List the ADCES7 self-care behaviors and write one assessment question for each that would surface a patient's barrier

  • Demonstrate motivational interviewing by writing two dialogue excerpts that show open questions, reflections, and change talk rather than advice-giving

  • Apply a validated screen for diabetes distress and depressive symptoms and describe referral thresholds and follow-up steps

  • Design a DSMES session outline that incorporates health literacy principles, teach-back, and cultural tailoring

  • Identify social determinants of health and match each to a concrete community or financial resource a diabetes care and education specialist could connect a patient to

Your checkpoint

A full 45-minute DSMES session plan with objectives, activities, teach-back questions, and an evaluation method, plus two MI dialogue scripts

Week 7

Diabetes pathophysiology, epidemiology, and prevention & Diabetes self-management education, behavior change, and psychosocial care

  • Explain the epidemiology of type 1, type 2, and gestational diabetes, including trends in incidence, disparities, and the distinction between incidence and prevalence

  • Summarize primary prevention evidence for type 2 diabetes prevention programs, including referral pathways for prediabetes and screening recommendations for asymptomatic adults

  • Connect behavior-change theory (stages of change, social cognitive theory, self-efficacy) to specific education strategies you would use in a session

  • Integrate domains by writing five cross-cutting vignettes that each require a pharmacotherapy, nutrition, behavioral, and monitoring decision

Your checkpoint

Five integrated vignettes with model answers and rationale, each citing the domain knowledge applied

Week 8

Clinical management: pharmacotherapy and glycemic targets & Monitoring, technology, complications, and special populations & Nutrition, physical activity, and weight management & Diabetes self-management education, behavior change, and psychosocial care & Diabetes pathophysiology, epidemiology, and prevention

  • Re-take every self-written quiz from weeks 1 to 7 and log every missed item with the underlying concept and a corrected explanation

  • Answer 100 self-authored or freely available practice items under timed conditions and categorize errors by domain

  • Re-teach your three weakest concepts aloud or in writing without notes to confirm mastery

  • Finalize a one-page summary sheet of high-yield numbers (diagnostic cutoffs, glycemic targets, screening intervals, insulin titration rules) and commit it to memory

Your checkpoint

A scored 100-item timed practice set with an error log and a finalized one-page high-yield numbers sheet

Milestones

Week 2: Closed-book recall of at least 10 antihyperglycemic agents with mechanism, key adverse effect, and one monitoring parameter each at 90% accuracy

Week 4: Correctly interpret three CGM reports and answer all four special-population cases against your own rubric with no unresolved gaps

Week 6: Complete DSMES session plan and MI scripts reviewed against a self-made checklist, scoring at least 80%

Week 8: Score 80% or higher on a 100-item timed mixed-domain set, with every missed item logged and re-explained

CDCES exam day

Your checklist

Unexpired government-issued photo ID with your signature

A driver's license, state ID, or passport is the typical standard at computer-based testing centers. The first and last name on the ID must match your registration exactly; if you have a nickname, a hyphenated name, or a recent name change, call the testing provider before test day rather than sorting it out at check-in.

Appointment confirmation and test center address/phone number

Save a screenshot or printout of your confirmation, including the appointment time, confirmation number, and the testing provider's phone number. Re-check the address the night before; test centers are sometimes inside office parks or shared buildings with confusing entrances.

Two forms of ID, if the provider requires a secondary ID

Some testing programs accept a single government-issued photo ID; others want a second form (credit card, signed ID). Check the current candidate handbook or your appointment confirmation to see what applies to you.

Travel and parking plan with a 30-minute buffer

Build in extra time for parking, security screening, and check-in. Aim to walk through the door at least 30 minutes before your appointment. Confirm in advance what the provider's cutoff is for late arrivals, since arriving after it may mean forfeiting your seat and fee.

A snack and water for after the exam (or for an authorized break)

Food and drink are generally not allowed at the workstation. In most centers personal items go into a locker you may be able to access during an unscheduled break, but confirm the center's policy - and note that any break time is usually deducted from your testing time.

Layers of clothing you can adjust

Testing rooms are often cold and a light jacket or cardigan is easy to remove. Avoid clothing with large pockets, hoods, or logos if the center's security screening is strict.

Eyeglasses, contacts, and any comfort items you rely on

Bring your glasses even if you normally wear contacts. For medications, inhalers, or medically necessary items, ask the testing provider in advance about the accommodation and storage process rather than assuming you can carry them in.

Confirm what testing tools are provided (on-screen or physical calculator, note board, marker)

Many computer-based testing centers supply an erasable note board and marker and some exams offer an on-screen calculator. Do not assume either is available for this exam, and do not bring your own unless the provider explicitly permits it.

If testing by live remote proctoring: complete the system check and prep your room

Remote-proctored delivery typically requires a webcam, microphone, a stable connection, a private quiet room, a clear desk, and a room scan at check-in. Run the equipment test and photo upload ahead of time, and confirm whether remote delivery is offered for this exam.

Leave prohibited items behind or plan to store them

Phones, smartwatches, fitness trackers, earbuds, notes, textbooks, and study cards are not allowed in the testing room. Most centers provide a locker, but items left in a car or at home remove the temptation and the risk of a conduct violation.

A short, written review sheet you will read only the day before

Limit last-minute review to a one- or two-page summary of concepts you have already learned - insulin action curves, carbohydrate counting basics, A1C and glucose target ranges, sick-day rules, hypoglycemia treatment. No new material in the final 24 hours.

Alarm set plus a backup alarm, and a sleep plan

Set two alarms and, if you are traveling, request a wake-up call. Going to bed at your normal time beats going to bed unusually early, which often backfires.

Plan the day

72 hours before

Reconfirm the appointment time, location, and ID requirements with the testing provider, then do a dry run of the commute at the same time of day if the center is unfamiliar. Read the current candidate handbook once more for rules on breaks, personal items, late arrival, and rescheduling. Stop studying new content and switch to reviewing your own summary sheets and missed-practice-question log.

48 hours before

Take one final timed practice set under exam-like conditions, then stop. Use the results only to pick two or three weak areas for light review. Protect your sleep schedule starting now; do not plan late-night cramming sessions.

24 hours before

Pack your bag: ID, confirmation, glasses, layers, snack, and directions. Charge nothing you cannot bring in - leave the phone and smartwatch at home or in the car. Confirm the weather and any transit disruptions. Do a light pass (60–90 minutes maximum) over high-yield summaries, eat a normal dinner, and set two alarms. Avoid alcohol and heavy caffeine.

The morning of

Eat a normal breakfast with protein and fiber; going in hungry or over-caffeinated hurts focus more than a missed study hour helps. Arrive early with your ID in hand. At check-in, follow the proctor's instructions on lockers, pockets, and the security scan, and read the nondisclosure agreement carefully before accepting it.

First two minutes at the workstation

Before the clock matters, use the note board to write down reference values you have memorized - glucose targets, A1C-to-average-glucose relationships, insulin onset/peak/duration, hypoglycemia treatment grams. This frees working memory and gives you a calm starting ritual.

During the test: pacing

Confirm the item count and time limit from the candidate handbook and divide accordingly - for a 200-item, 4-hour exam that is roughly 70 seconds per item, which leaves a review buffer. Answer every item as you go; do not leave anything blank. Flag uncertain items and move on rather than sinking three minutes into one question.

During the test: question strategy

Read the stem for the actual task word (best, first, initial, priority) and cover the options before reading them. Eliminate two choices, then decide. For math or insulin-dose items, estimate the answer before computing and check whether the units and the magnitude make clinical sense. Be wary of absolutes and of options that are true statements but do not answer the question asked.

During the test: breaks

If you take an unscheduled break, the clock generally keeps running - confirm this in the candidate handbook. A 2-minute stand-and-stretch at the workstation, a sip of water, and three slow breaths is often enough to reset focus without spending test time.

After you finish

Follow the proctor's exit instructions and collect your belongings. Ask how and when your score report is delivered and keep it. If the result is below passing, contact the certifying board directly for the retake waiting period, application process, and any score-report detail before making a plan.

Rules to check

  • Bring the exact name on your registration. If your ID does not match it, contact the testing provider before test day - a mismatch discovered at check-in can mean being turned away.

  • Expect a security screening. Pockets are emptied, a wand or metal detector may be used, and you may be asked to remove glasses or turn out pockets. This is routine; cooperate and keep the line moving.

  • No phones, smartwatches, fitness trackers, or earbuds in the testing room, even powered off in a pocket. Store them in the provided locker or leave them behind. Touching a device during testing is typically treated as a conduct violation.

  • You will accept a nondisclosure agreement before the exam starts. Discussing, reconstructing, or sharing specific exam questions afterward violates that agreement and can jeopardize your certification - describe only your general impressions if you debrief with colleagues.

  • Unscheduled breaks are usually permitted but the clock generally continues to run, and you may be re-screened on return. Any pre-approved accommodations or scheduled breaks follow a separate process that must be arranged before test day, not requested at the door.

  • The exam is scored against a fixed standard rather than against other candidates, and results are reported as pass/fail - the exact scaled-score passing point is set by the certifying board and is not something to reverse-engineer. Confirm how and when your official score report is delivered.

  • Arriving after the provider's cutoff may result in denied entry and forfeiture of your fee, and rescheduling usually has a deadline and a charge. Read the current reschedule/cancellation policy and know it before the final week.

  • If something goes wrong - a technology failure, an illness, a family emergency - stop and notify the proctor or testing provider immediately and get documentation. Post-hoc appeals are much harder than an incident report filed the same day.

CDCES FAQ

How many CDCES practice questions are available?

The practice set has 200 CDCES questions. Each one includes the choices, the correct answer, and an explanation, and the set is free to read with no signup.

How many CDCES flashcards are available?

The flashcard set has 32 CDCES cards. Each card shows the term and its definition.

Which topics does the CDCES study material cover?

The CDCES study material has 5 sections, including Diabetes Pathophysiology, Epidemiology, and Prevention, Pharmacotherapy and Glycemic Targets, and Nutrition, Physical Activity, and Weight Management.